date generated: 2022-03-15
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik 0.2684894
## 0610009E02Rik -0.7521235
## 0610009L18Rik -1.1838923
## 0610010K14Rik -0.0433030
## 0610012G03Rik -0.1930476
## 0610030E20Rik 1.0496464
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 16805 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8283 |
| num_profile_genes_not_in_sets | 8522 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 437 |
| num_genesets_included | 1167 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| MET ACTIVATES RAP1 AND RAC1 | 11 | 1.04e-03 | -0.571 | 2.96e-02 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.15e-03 | -0.534 | 5.11e-02 |
| ACTIVATION OF RAC1 | 13 | 1.76e-03 | -0.501 | 4.48e-02 |
| INITIAL TRIGGERING OF COMPLEMENT | 10 | 1.00e-02 | 0.470 | 1.54e-01 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 6.33e-03 | 0.437 | 1.15e-01 |
| EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-12 | 0.437 | 2.18e-09 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 1.22e-02 | -0.437 | 1.71e-01 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 6.81e-03 | 0.433 | 1.22e-01 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 2.78e-03 | 0.432 | 6.36e-02 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 9.09e-04 | 0.428 | 2.65e-02 |
| SCAVENGING BY CLASS A RECEPTORS | 14 | 7.55e-03 | 0.412 | 1.31e-01 |
| SEROTONIN RECEPTORS | 10 | 2.92e-02 | -0.398 | 2.96e-01 |
| COLLAGEN CHAIN TRIMERIZATION | 40 | 1.46e-05 | 0.396 | 8.12e-04 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 6.15e-03 | -0.396 | 1.14e-01 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.89e-02 | 0.376 | 2.27e-01 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 3.75e-10 | 0.374 | 7.95e-08 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.77e-02 | 0.367 | 2.92e-01 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 9.65e-07 | 0.357 | 7.04e-05 |
| NONSENSE MEDIATED DECAY NMD | 109 | 4.09e-10 | 0.347 | 7.95e-08 |
| AGGREPHAGY | 35 | 5.20e-04 | 0.339 | 1.64e-02 |
| ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 6.37e-02 | -0.339 | 4.49e-01 |
| COMPLEMENT CASCADE | 22 | 6.03e-03 | 0.338 | 1.14e-01 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 6.03e-03 | 0.338 | 1.14e-01 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.32e-02 | -0.337 | 1.80e-01 |
| CROSSLINKING OF COLLAGEN FIBRILS | 14 | 2.90e-02 | 0.337 | 2.96e-01 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.68e-03 | 0.334 | 9.76e-02 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 8.55e-03 | -0.332 | 1.39e-01 |
| SELENOAMINO ACID METABOLISM | 108 | 2.69e-09 | 0.331 | 4.36e-07 |
| P75NTR SIGNALS VIA NF KB | 16 | 2.50e-02 | 0.324 | 2.73e-01 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 2.25e-02 | -0.320 | 2.57e-01 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.06e-02 | -0.319 | 4.80e-01 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 8.18e-05 | 0.319 | 3.54e-03 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.55e-08 | 0.318 | 1.81e-06 |
| FERTILIZATION | 12 | 5.67e-02 | 0.318 | 4.34e-01 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.36e-02 | 0.317 | 2.62e-01 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.78e-02 | 0.317 | 3.87e-01 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 6.87e-02 | -0.317 | 4.49e-01 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.08e-02 | -0.315 | 4.49e-01 |
| INSULIN PROCESSING | 24 | 7.89e-03 | -0.313 | 1.32e-01 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 1.84e-02 | 0.313 | 2.27e-01 |
| PEXOPHAGY | 11 | 7.55e-02 | 0.310 | 4.68e-01 |
| TIGHT JUNCTION INTERACTIONS | 18 | 2.31e-02 | -0.309 | 2.60e-01 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 2.05e-02 | -0.307 | 2.36e-01 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.53e-02 | 0.307 | 4.27e-01 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.88e-05 | 0.307 | 9.98e-04 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 8.04e-02 | -0.304 | 4.80e-01 |
| COLLAGEN DEGRADATION | 51 | 1.87e-04 | 0.303 | 7.26e-03 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 7.02e-02 | -0.302 | 4.49e-01 |
| CGMP EFFECTS | 15 | 4.32e-02 | -0.301 | 3.71e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 6.02e-02 | 0.301 | 4.47e-01 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| MET ACTIVATES RAP1 AND RAC1 | 11 | 1.04e-03 | -5.71e-01 | 2.96e-02 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 2.15e-03 | -5.34e-01 | 5.11e-02 |
| ACTIVATION OF RAC1 | 13 | 1.76e-03 | -5.01e-01 | 4.48e-02 |
| INITIAL TRIGGERING OF COMPLEMENT | 10 | 1.00e-02 | 4.70e-01 | 1.54e-01 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 6.33e-03 | 4.37e-01 | 1.15e-01 |
| EUKARYOTIC TRANSLATION ELONGATION | 87 | 1.86e-12 | 4.37e-01 | 2.18e-09 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 1.22e-02 | -4.37e-01 | 1.71e-01 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 6.81e-03 | 4.33e-01 | 1.22e-01 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 16 | 2.78e-03 | 4.32e-01 | 6.36e-02 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 9.09e-04 | 4.28e-01 | 2.65e-02 |
| SCAVENGING BY CLASS A RECEPTORS | 14 | 7.55e-03 | 4.12e-01 | 1.31e-01 |
| SEROTONIN RECEPTORS | 10 | 2.92e-02 | -3.98e-01 | 2.96e-01 |
| COLLAGEN CHAIN TRIMERIZATION | 40 | 1.46e-05 | 3.96e-01 | 8.12e-04 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 6.15e-03 | -3.96e-01 | 1.14e-01 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.89e-02 | 3.76e-01 | 2.27e-01 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 94 | 3.75e-10 | 3.74e-01 | 7.95e-08 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 2.77e-02 | 3.67e-01 | 2.92e-01 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 9.65e-07 | 3.57e-01 | 7.04e-05 |
| NONSENSE MEDIATED DECAY NMD | 109 | 4.09e-10 | 3.47e-01 | 7.95e-08 |
| AGGREPHAGY | 35 | 5.20e-04 | 3.39e-01 | 1.64e-02 |
| ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 6.37e-02 | -3.39e-01 | 4.49e-01 |
| COMPLEMENT CASCADE | 22 | 6.03e-03 | 3.38e-01 | 1.14e-01 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 22 | 6.03e-03 | 3.38e-01 | 1.14e-01 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 1.32e-02 | -3.37e-01 | 1.80e-01 |
| CROSSLINKING OF COLLAGEN FIBRILS | 14 | 2.90e-02 | 3.37e-01 | 2.96e-01 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 4.68e-03 | 3.34e-01 | 9.76e-02 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 21 | 8.55e-03 | -3.32e-01 | 1.39e-01 |
| SELENOAMINO ACID METABOLISM | 108 | 2.69e-09 | 3.31e-01 | 4.36e-07 |
| P75NTR SIGNALS VIA NF KB | 16 | 2.50e-02 | 3.24e-01 | 2.73e-01 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 2.25e-02 | -3.20e-01 | 2.57e-01 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 8.06e-02 | -3.19e-01 | 4.80e-01 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 51 | 8.18e-05 | 3.19e-01 | 3.54e-03 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 1.55e-08 | 3.18e-01 | 1.81e-06 |
| FERTILIZATION | 12 | 5.67e-02 | 3.18e-01 | 4.34e-01 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 2.36e-02 | 3.17e-01 | 2.62e-01 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 4.78e-02 | 3.17e-01 | 3.87e-01 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 6.87e-02 | -3.17e-01 | 4.49e-01 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 7.08e-02 | -3.15e-01 | 4.49e-01 |
| INSULIN PROCESSING | 24 | 7.89e-03 | -3.13e-01 | 1.32e-01 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 1.84e-02 | 3.13e-01 | 2.27e-01 |
| PEXOPHAGY | 11 | 7.55e-02 | 3.10e-01 | 4.68e-01 |
| TIGHT JUNCTION INTERACTIONS | 18 | 2.31e-02 | -3.09e-01 | 2.60e-01 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 2.05e-02 | -3.07e-01 | 2.36e-01 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 5.53e-02 | 3.07e-01 | 4.27e-01 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 1.88e-05 | 3.07e-01 | 9.98e-04 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 11 | 8.04e-02 | -3.04e-01 | 4.80e-01 |
| COLLAGEN DEGRADATION | 51 | 1.87e-04 | 3.03e-01 | 7.26e-03 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 7.02e-02 | -3.02e-01 | 4.49e-01 |
| CGMP EFFECTS | 15 | 4.32e-02 | -3.01e-01 | 3.71e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 13 | 6.02e-02 | 3.01e-01 | 4.47e-01 |
| COLLAGEN FORMATION | 79 | 3.88e-06 | 3.01e-01 | 2.66e-04 |
| ACTIVATION OF SMO | 16 | 3.76e-02 | 3.00e-01 | 3.48e-01 |
| EUKARYOTIC TRANSLATION INITIATION | 114 | 3.30e-08 | 3.00e-01 | 3.20e-06 |
| JOSEPHIN DOMAIN DUBS | 11 | 8.80e-02 | 2.97e-01 | 4.84e-01 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 1.18e-02 | 2.97e-01 | 1.71e-01 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 1.05e-01 | -2.96e-01 | 5.28e-01 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 11 | 9.01e-02 | 2.95e-01 | 4.86e-01 |
| REGULATION OF IFNG SIGNALING | 13 | 6.66e-02 | -2.94e-01 | 4.49e-01 |
| INTERFERON ALPHA BETA SIGNALING | 52 | 2.54e-04 | -2.93e-01 | 9.25e-03 |
| ECM PROTEOGLYCANS | 65 | 4.38e-05 | 2.93e-01 | 2.04e-03 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 6.74e-02 | 2.93e-01 | 4.49e-01 |
| PYRIMIDINE SALVAGE | 10 | 1.12e-01 | -2.90e-01 | 5.39e-01 |
| COMPLEX I BIOGENESIS | 56 | 1.82e-04 | 2.89e-01 | 7.26e-03 |
| MET ACTIVATES PTK2 SIGNALING | 29 | 7.19e-03 | 2.88e-01 | 1.27e-01 |
| SMOOTH MUSCLE CONTRACTION | 33 | 4.28e-03 | 2.87e-01 | 9.24e-02 |
| INTERLEUKIN 37 SIGNALING | 19 | 3.17e-02 | 2.85e-01 | 3.05e-01 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 5.89e-02 | -2.82e-01 | 4.40e-01 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.86e-02 | 2.81e-01 | 4.49e-01 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 32 | 5.94e-03 | 2.81e-01 | 1.14e-01 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 6.91e-02 | -2.81e-01 | 4.49e-01 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 8.12e-02 | 2.79e-01 | 4.81e-01 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 12 | 9.80e-02 | 2.76e-01 | 5.06e-01 |
| MRNA SPLICING | 188 | 8.46e-11 | 2.75e-01 | 2.47e-08 |
| ELASTIC FIBRE FORMATION | 37 | 3.89e-03 | 2.74e-01 | 8.59e-02 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 1.35e-01 | -2.73e-01 | 5.60e-01 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 1.02e-01 | 2.72e-01 | 5.22e-01 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 20 | 3.56e-02 | -2.71e-01 | 3.32e-01 |
| PYRIMIDINE CATABOLISM | 10 | 1.37e-01 | -2.71e-01 | 5.60e-01 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 1.05e-01 | -2.70e-01 | 5.28e-01 |
| CS DS DEGRADATION | 14 | 8.37e-02 | 2.67e-01 | 4.84e-01 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 4.46e-04 | 2.64e-01 | 1.45e-02 |
| CELL CELL JUNCTION ORGANIZATION | 50 | 1.31e-03 | -2.63e-01 | 3.56e-02 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 160 | 1.22e-08 | 2.61e-01 | 1.59e-06 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 12 | 1.19e-01 | -2.60e-01 | 5.54e-01 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.15e-02 | 2.59e-01 | 3.05e-01 |
| PROLONGED ERK ACTIVATION EVENTS | 14 | 9.57e-02 | -2.57e-01 | 4.99e-01 |
| HSF1 DEPENDENT TRANSACTIVATION | 34 | 9.65e-03 | 2.57e-01 | 1.50e-01 |
| P75NTR REGULATES AXONOGENESIS | 10 | 1.60e-01 | -2.56e-01 | 6.02e-01 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 1.25e-01 | -2.56e-01 | 5.56e-01 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 11 | 1.48e-01 | -2.52e-01 | 5.78e-01 |
| DISEASES OF DNA REPAIR | 11 | 1.53e-01 | 2.49e-01 | 5.87e-01 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 1.56e-01 | 2.47e-01 | 5.91e-01 |
| RHO GTPASES ACTIVATE CIT | 18 | 7.04e-02 | 2.46e-01 | 4.49e-01 |
| SYNDECAN INTERACTIONS | 26 | 3.06e-02 | 2.45e-01 | 3.05e-01 |
| RMTS METHYLATE HISTONE ARGININES | 42 | 6.13e-03 | 2.44e-01 | 1.14e-01 |
| RAP1 SIGNALLING | 15 | 1.01e-01 | -2.44e-01 | 5.18e-01 |
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 1.82e-01 | -2.44e-01 | 6.38e-01 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 1.64e-01 | 2.42e-01 | 6.08e-01 |
| CELLULAR RESPONSE TO STARVATION | 145 | 5.19e-07 | 2.42e-01 | 4.33e-05 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 1.86e-01 | -2.42e-01 | 6.43e-01 |
| CHAPERONE MEDIATED AUTOPHAGY | 20 | 6.19e-02 | 2.41e-01 | 4.49e-01 |
| AMINE LIGAND BINDING RECEPTORS | 31 | 2.04e-02 | -2.41e-01 | 2.36e-01 |
| ATTENUATION PHASE | 24 | 4.16e-02 | 2.40e-01 | 3.60e-01 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 5.42e-02 | 2.37e-01 | 4.24e-01 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 6.66e-02 | -2.37e-01 | 4.49e-01 |
| RAB GERANYLGERANYLATION | 57 | 2.00e-03 | -2.37e-01 | 4.96e-02 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 1.75e-01 | 2.36e-01 | 6.24e-01 |
| SIGNALING BY KIT IN DISEASE | 20 | 6.81e-02 | -2.36e-01 | 4.49e-01 |
| POLO LIKE KINASE MEDIATED EVENTS | 13 | 1.44e-01 | 2.34e-01 | 5.71e-01 |
| REPRESSION OF WNT TARGET GENES | 14 | 1.30e-01 | 2.34e-01 | 5.60e-01 |
| SIGNALING BY FLT3 FUSION PROTEINS | 18 | 8.66e-02 | -2.33e-01 | 4.84e-01 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 34 | 1.88e-02 | -2.33e-01 | 2.27e-01 |
| RRNA PROCESSING | 194 | 3.06e-08 | 2.31e-01 | 3.20e-06 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 1.16e-02 | -2.31e-01 | 1.71e-01 |
| DISEASES OF MITOTIC CELL CYCLE | 37 | 1.53e-02 | -2.31e-01 | 1.98e-01 |
| REGULATION OF KIT SIGNALING | 16 | 1.14e-01 | -2.28e-01 | 5.39e-01 |
| CD28 CO STIMULATION | 30 | 3.09e-02 | -2.28e-01 | 3.05e-01 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 9.45e-02 | -2.28e-01 | 4.97e-01 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 8.60e-02 | -2.28e-01 | 4.84e-01 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.13e-01 | 2.27e-01 | 6.59e-01 |
| DNA DAMAGE BYPASS | 46 | 7.61e-03 | -2.27e-01 | 1.31e-01 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 3.41e-02 | -2.27e-01 | 3.24e-01 |
| GAP JUNCTION ASSEMBLY | 21 | 7.25e-02 | 2.26e-01 | 4.57e-01 |
| TRANSLATION | 286 | 5.63e-11 | 2.26e-01 | 2.19e-08 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.33e-01 | -2.24e-01 | 5.60e-01 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 2.99e-09 | 2.24e-01 | 4.36e-07 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 3.11e-02 | -2.24e-01 | 3.05e-01 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 21 | 7.62e-02 | -2.24e-01 | 4.70e-01 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 4.15e-02 | 2.23e-01 | 3.60e-01 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 15 | 1.37e-01 | -2.22e-01 | 5.60e-01 |
| INTERFERON GAMMA SIGNALING | 73 | 1.07e-03 | -2.22e-01 | 2.96e-02 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 29 | 3.89e-02 | -2.22e-01 | 3.54e-01 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.24e-04 | 2.20e-01 | 2.22e-02 |
| SIGNALING BY HIPPO | 20 | 8.88e-02 | -2.20e-01 | 4.84e-01 |
| UNWINDING OF DNA | 12 | 1.89e-01 | -2.19e-01 | 6.43e-01 |
| IRE1ALPHA ACTIVATES CHAPERONES | 49 | 8.28e-03 | 2.18e-01 | 1.36e-01 |
| ANCHORING FIBRIL FORMATION | 13 | 1.77e-01 | 2.16e-01 | 6.28e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 11 | 2.15e-01 | 2.16e-01 | 6.63e-01 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 26 | 5.73e-02 | -2.15e-01 | 4.34e-01 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 1.24e-01 | -2.15e-01 | 5.56e-01 |
| ADHERENS JUNCTIONS INTERACTIONS | 30 | 4.15e-02 | -2.15e-01 | 3.60e-01 |
| PRE NOTCH PROCESSING IN GOLGI | 17 | 1.25e-01 | 2.15e-01 | 5.56e-01 |
| MET ACTIVATES RAS SIGNALING | 10 | 2.42e-01 | -2.14e-01 | 6.78e-01 |
| MITOCHONDRIAL TRANSLATION | 93 | 3.68e-04 | 2.14e-01 | 1.26e-02 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 1.52e-01 | -2.14e-01 | 5.84e-01 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 31 | 3.94e-02 | 2.14e-01 | 3.54e-01 |
| MRNA SPLICING MINOR PATHWAY | 52 | 8.72e-03 | 2.10e-01 | 1.39e-01 |
| SHC MEDIATED CASCADE FGFR3 | 12 | 2.09e-01 | 2.10e-01 | 6.56e-01 |
| INFLUENZA INFECTION | 145 | 1.34e-05 | 2.10e-01 | 7.81e-04 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 1.47e-01 | -2.09e-01 | 5.77e-01 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 5.38e-05 | 2.09e-01 | 2.41e-03 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 1.93e-01 | 2.09e-01 | 6.45e-01 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 2.54e-01 | 2.08e-01 | 6.89e-01 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 1.07e-01 | -2.08e-01 | 5.33e-01 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 11 | 2.33e-01 | 2.08e-01 | 6.72e-01 |
| DARPP 32 EVENTS | 23 | 8.77e-02 | -2.06e-01 | 4.84e-01 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 21 | 1.03e-01 | -2.05e-01 | 5.22e-01 |
| KERATAN SULFATE DEGRADATION | 11 | 2.39e-01 | 2.05e-01 | 6.77e-01 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 3.79e-04 | 2.04e-01 | 1.26e-02 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 15 | 1.73e-01 | 2.03e-01 | 6.21e-01 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 13 | 2.08e-01 | 2.02e-01 | 6.56e-01 |
| GABA RECEPTOR ACTIVATION | 52 | 1.21e-02 | -2.01e-01 | 1.71e-01 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 33 | 4.57e-02 | -2.01e-01 | 3.84e-01 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 1.11e-01 | -2.01e-01 | 5.39e-01 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 20 | 1.20e-01 | -2.01e-01 | 5.56e-01 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 2.11e-01 | 2.00e-01 | 6.59e-01 |
| GLYCOGEN METABOLISM | 25 | 8.59e-02 | 1.98e-01 | 4.84e-01 |
| REGULATION OF IFNA SIGNALING | 12 | 2.34e-01 | -1.98e-01 | 6.72e-01 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 2.81e-01 | -1.97e-01 | 7.03e-01 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 1.38e-01 | 1.97e-01 | 5.60e-01 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 1.90e-01 | -1.96e-01 | 6.43e-01 |
| LYSINE CATABOLISM | 11 | 2.62e-01 | 1.95e-01 | 6.95e-01 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 59 | 9.49e-03 | -1.95e-01 | 1.50e-01 |
| TRNA AMINOACYLATION | 42 | 2.86e-02 | 1.95e-01 | 2.95e-01 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 2.62e-01 | -1.95e-01 | 6.95e-01 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 13 | 2.23e-01 | 1.95e-01 | 6.69e-01 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 19 | 1.42e-01 | -1.94e-01 | 5.67e-01 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 1.93e-01 | -1.94e-01 | 6.45e-01 |
| INTERFERON SIGNALING | 160 | 2.26e-05 | -1.94e-01 | 1.10e-03 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 15 | 1.94e-01 | 1.94e-01 | 6.45e-01 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 4.43e-02 | -1.94e-01 | 3.78e-01 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 2.29e-01 | 1.93e-01 | 6.72e-01 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 3.31e-02 | 1.92e-01 | 3.16e-01 |
| TERMINATION OF O GLYCAN BIOSYNTHESIS | 10 | 2.93e-01 | 1.92e-01 | 7.06e-01 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 2.94e-01 | -1.92e-01 | 7.07e-01 |
| PYRUVATE METABOLISM | 27 | 8.61e-02 | -1.91e-01 | 4.84e-01 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 55 | 1.45e-02 | 1.91e-01 | 1.91e-01 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 2.35e-01 | 1.90e-01 | 6.72e-01 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 2.80e-01 | 1.88e-01 | 7.03e-01 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 11 | 2.81e-01 | -1.88e-01 | 7.03e-01 |
| NCAM1 INTERACTIONS | 40 | 4.00e-02 | 1.88e-01 | 3.54e-01 |
| SIGNALING BY ACTIVIN | 12 | 2.62e-01 | -1.87e-01 | 6.95e-01 |
| SHC1 EVENTS IN EGFR SIGNALING | 11 | 2.83e-01 | -1.87e-01 | 7.03e-01 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 1.22e-01 | -1.86e-01 | 5.56e-01 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 2.72e-02 | 1.86e-01 | 2.91e-01 |
| LGI ADAM INTERACTIONS | 14 | 2.28e-01 | 1.86e-01 | 6.72e-01 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 3.10e-01 | -1.85e-01 | 7.33e-01 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.87e-01 | 1.85e-01 | 6.43e-01 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 12 | 2.69e-01 | -1.84e-01 | 7.01e-01 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 33 | 6.86e-02 | 1.83e-01 | 4.49e-01 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.29e-01 | -1.83e-01 | 5.60e-01 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 1.79e-01 | 1.83e-01 | 6.34e-01 |
| PI 3K CASCADE FGFR3 | 12 | 2.75e-01 | 1.82e-01 | 7.03e-01 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 1.39e-01 | 1.82e-01 | 5.62e-01 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 310 | 3.82e-08 | 1.82e-01 | 3.43e-06 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 55 | 2.01e-02 | -1.81e-01 | 2.36e-01 |
| BILE ACID AND BILE SALT METABOLISM | 25 | 1.20e-01 | 1.80e-01 | 5.56e-01 |
| GLYCOGEN STORAGE DISEASES | 12 | 2.81e-01 | 1.80e-01 | 7.03e-01 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 2.45e-01 | 1.80e-01 | 6.85e-01 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.65e-01 | 1.79e-01 | 6.08e-01 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 2.82e-01 | -1.79e-01 | 7.03e-01 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.37e-01 | 1.79e-01 | 5.60e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 2.32e-01 | 1.78e-01 | 6.72e-01 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 30 | 9.12e-02 | -1.78e-01 | 4.87e-01 |
| G PROTEIN BETA GAMMA SIGNALLING | 30 | 9.14e-02 | -1.78e-01 | 4.87e-01 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 2.50e-01 | -1.78e-01 | 6.88e-01 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 3.31e-01 | 1.77e-01 | 7.42e-01 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 8.74e-02 | 1.77e-01 | 4.84e-01 |
| PROCESSING OF SMDT1 | 16 | 2.19e-01 | -1.77e-01 | 6.68e-01 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 45 | 3.98e-02 | -1.77e-01 | 3.54e-01 |
| SIGNALING BY BMP | 24 | 1.33e-01 | -1.77e-01 | 5.60e-01 |
| PLATELET CALCIUM HOMEOSTASIS | 25 | 1.26e-01 | -1.77e-01 | 5.57e-01 |
| ACTIVATION OF BH3 ONLY PROTEINS | 28 | 1.08e-01 | -1.76e-01 | 5.34e-01 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 1.37e-01 | -1.75e-01 | 5.60e-01 |
| SODIUM CALCIUM EXCHANGERS | 10 | 3.38e-01 | -1.75e-01 | 7.42e-01 |
| COPII MEDIATED VESICLE TRANSPORT | 66 | 1.40e-02 | -1.75e-01 | 1.86e-01 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.03e-01 | -1.75e-01 | 5.22e-01 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 2.76e-01 | -1.74e-01 | 7.03e-01 |
| CELLULAR HEXOSE TRANSPORT | 11 | 3.17e-01 | -1.74e-01 | 7.36e-01 |
| RHOA GTPASE CYCLE | 143 | 3.25e-04 | 1.74e-01 | 1.15e-02 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 1.24e-01 | 1.74e-01 | 5.56e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 19 | 1.89e-01 | 1.74e-01 | 6.43e-01 |
| FGFR2 ALTERNATIVE SPLICING | 26 | 1.25e-01 | 1.74e-01 | 5.56e-01 |
| SIGNALING BY ROBO RECEPTORS | 205 | 2.25e-05 | 1.72e-01 | 1.10e-03 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 2.35e-01 | -1.72e-01 | 6.72e-01 |
| INTERLEUKIN 27 SIGNALING | 10 | 3.50e-01 | 1.71e-01 | 7.50e-01 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 60 | 2.27e-02 | 1.70e-01 | 2.57e-01 |
| LONG TERM POTENTIATION | 23 | 1.59e-01 | -1.70e-01 | 6.00e-01 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 1.89e-01 | 1.70e-01 | 6.43e-01 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 19 | 2.01e-01 | -1.69e-01 | 6.51e-01 |
| ANTIMICROBIAL PEPTIDES | 13 | 2.91e-01 | 1.69e-01 | 7.05e-01 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 28 | 1.21e-01 | -1.69e-01 | 5.56e-01 |
| SELECTIVE AUTOPHAGY | 72 | 1.32e-02 | 1.69e-01 | 1.80e-01 |
| ENDOGENOUS STEROLS | 21 | 1.81e-01 | 1.69e-01 | 6.36e-01 |
| O LINKED GLYCOSYLATION OF MUCINS | 41 | 6.31e-02 | -1.68e-01 | 4.49e-01 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 11 | 3.37e-01 | -1.67e-01 | 7.42e-01 |
| PHASE 0 RAPID DEPOLARISATION | 31 | 1.07e-01 | -1.67e-01 | 5.33e-01 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 37 | 7.85e-02 | -1.67e-01 | 4.77e-01 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 4.52e-02 | 1.67e-01 | 3.82e-01 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 23 | 1.67e-01 | -1.66e-01 | 6.10e-01 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 67 | 1.88e-02 | -1.66e-01 | 2.27e-01 |
| PURINE CATABOLISM | 16 | 2.51e-01 | 1.66e-01 | 6.88e-01 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 1.45e-01 | 1.65e-01 | 5.72e-01 |
| MATURATION OF NUCLEOPROTEIN | 10 | 3.68e-01 | -1.64e-01 | 7.67e-01 |
| EXTRACELLULAR MATRIX ORGANIZATION | 242 | 1.17e-05 | 1.64e-01 | 7.17e-04 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 3.70e-01 | -1.64e-01 | 7.67e-01 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 2.80e-01 | -1.61e-01 | 7.03e-01 |
| PI3K EVENTS IN ERBB2 SIGNALING | 15 | 2.82e-01 | -1.60e-01 | 7.03e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 3.18e-01 | 1.60e-01 | 7.37e-01 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 21 | 2.05e-01 | 1.60e-01 | 6.53e-01 |
| FORMATION OF APOPTOSOME | 10 | 3.82e-01 | -1.60e-01 | 7.74e-01 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 11 | 3.62e-01 | 1.59e-01 | 7.63e-01 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 8.69e-02 | 1.58e-01 | 4.84e-01 |
| LAMININ INTERACTIONS | 27 | 1.55e-01 | 1.58e-01 | 5.91e-01 |
| G2 M DNA DAMAGE CHECKPOINT | 65 | 2.83e-02 | -1.57e-01 | 2.95e-01 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 34 | 1.14e-01 | 1.57e-01 | 5.39e-01 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 3.92e-01 | -1.56e-01 | 7.76e-01 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 2.38e-01 | 1.56e-01 | 6.75e-01 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 3.78e-02 | 1.56e-01 | 3.48e-01 |
| METABOLISM OF RNA | 643 | 1.67e-11 | 1.56e-01 | 9.75e-09 |
| SIALIC ACID METABOLISM | 32 | 1.27e-01 | -1.56e-01 | 5.60e-01 |
| THE NLRP3 INFLAMMASOME | 15 | 3.00e-01 | -1.55e-01 | 7.16e-01 |
| GROWTH HORMONE RECEPTOR SIGNALING | 20 | 2.32e-01 | -1.54e-01 | 6.72e-01 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 13 | 3.37e-01 | 1.54e-01 | 7.42e-01 |
| INTEGRIN CELL SURFACE INTERACTIONS | 69 | 2.75e-02 | 1.54e-01 | 2.92e-01 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 13 | 3.38e-01 | -1.53e-01 | 7.42e-01 |
| RHO GTPASES ACTIVATE PAKS | 21 | 2.24e-01 | 1.53e-01 | 6.69e-01 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 2.49e-01 | -1.53e-01 | 6.88e-01 |
| RHOC GTPASE CYCLE | 73 | 2.46e-02 | 1.52e-01 | 2.70e-01 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 3.63e-01 | -1.52e-01 | 7.63e-01 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 285 | 1.11e-05 | -1.52e-01 | 7.17e-04 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 73 | 2.56e-02 | -1.51e-01 | 2.76e-01 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 2.67e-01 | 1.51e-01 | 7.01e-01 |
| ACYL CHAIN REMODELLING OF PS | 14 | 3.28e-01 | -1.51e-01 | 7.42e-01 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 11 | 3.88e-01 | -1.50e-01 | 7.74e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 2.70e-01 | 1.50e-01 | 7.01e-01 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 3.14e-01 | -1.50e-01 | 7.36e-01 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 2.99e-01 | -1.50e-01 | 7.16e-01 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 19 | 2.59e-01 | -1.50e-01 | 6.92e-01 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 3.50e-01 | -1.50e-01 | 7.50e-01 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 2.15e-01 | -1.49e-01 | 6.63e-01 |
| HEME SIGNALING | 45 | 8.34e-02 | -1.49e-01 | 4.84e-01 |
| CDC42 GTPASE CYCLE | 153 | 1.46e-03 | 1.49e-01 | 3.88e-02 |
| RHOBTB2 GTPASE CYCLE | 23 | 2.16e-01 | 1.49e-01 | 6.63e-01 |
| FORMATION OF THE CORNIFIED ENVELOPE | 29 | 1.66e-01 | 1.49e-01 | 6.08e-01 |
| KERATINIZATION | 29 | 1.66e-01 | 1.49e-01 | 6.08e-01 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 2.90e-01 | -1.48e-01 | 7.05e-01 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 3.75e-01 | 1.48e-01 | 7.72e-01 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 20 | 2.53e-01 | -1.48e-01 | 6.88e-01 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 3.39e-01 | -1.48e-01 | 7.42e-01 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 3.76e-01 | 1.48e-01 | 7.72e-01 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 6.37e-02 | 1.47e-01 | 4.49e-01 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 4.21e-01 | -1.47e-01 | 7.94e-01 |
| ERK MAPK TARGETS | 22 | 2.35e-01 | -1.46e-01 | 6.72e-01 |
| HDACS DEACETYLATE HISTONES | 45 | 8.97e-02 | 1.46e-01 | 4.86e-01 |
| FRS MEDIATED FGFR3 SIGNALING | 14 | 3.44e-01 | 1.46e-01 | 7.49e-01 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 3.12e-01 | 1.46e-01 | 7.33e-01 |
| VOLTAGE GATED POTASSIUM CHANNELS | 40 | 1.11e-01 | -1.46e-01 | 5.39e-01 |
| RHOBTB3 ATPASE CYCLE | 10 | 4.25e-01 | -1.46e-01 | 7.94e-01 |
| DISEASES OF IMMUNE SYSTEM | 23 | 2.30e-01 | 1.45e-01 | 6.72e-01 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 3.17e-01 | -1.45e-01 | 7.36e-01 |
| ERBB2 REGULATES CELL MOTILITY | 14 | 3.50e-01 | -1.44e-01 | 7.50e-01 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 1.65e-01 | 1.44e-01 | 6.08e-01 |
| INTERLEUKIN 10 SIGNALING | 18 | 2.90e-01 | -1.44e-01 | 7.05e-01 |
| MITOPHAGY | 29 | 1.83e-01 | 1.43e-01 | 6.40e-01 |
| COSTIMULATION BY THE CD28 FAMILY | 50 | 8.17e-02 | -1.42e-01 | 4.82e-01 |
| CA DEPENDENT EVENTS | 36 | 1.40e-01 | -1.42e-01 | 5.62e-01 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 4.14e-01 | 1.42e-01 | 7.92e-01 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 2.10e-01 | -1.42e-01 | 6.59e-01 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 2.73e-01 | -1.42e-01 | 7.02e-01 |
| CA2 PATHWAY | 56 | 6.69e-02 | -1.42e-01 | 4.49e-01 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 107 | 1.17e-02 | 1.41e-01 | 1.71e-01 |
| DEADENYLATION OF MRNA | 25 | 2.22e-01 | -1.41e-01 | 6.69e-01 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 1.70e-02 | 1.41e-01 | 2.15e-01 |
| DAP12 SIGNALING | 24 | 2.32e-01 | -1.41e-01 | 6.72e-01 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 1.10e-01 | -1.41e-01 | 5.39e-01 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 15 | 3.45e-01 | -1.41e-01 | 7.50e-01 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 1.97e-01 | 1.41e-01 | 6.45e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 1.99e-01 | 1.40e-01 | 6.46e-01 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 25 | 2.26e-01 | -1.40e-01 | 6.71e-01 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 12 | 4.04e-01 | 1.39e-01 | 7.85e-01 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 49 | 9.23e-02 | -1.39e-01 | 4.90e-01 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 13 | 3.86e-01 | -1.39e-01 | 7.74e-01 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 5.20e-02 | 1.38e-01 | 4.13e-01 |
| PROTEIN UBIQUITINATION | 69 | 4.77e-02 | -1.38e-01 | 3.87e-01 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 6.80e-02 | -1.37e-01 | 4.49e-01 |
| MET RECEPTOR RECYCLING | 10 | 4.52e-01 | -1.37e-01 | 8.10e-01 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 3.16e-01 | 1.36e-01 | 7.36e-01 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 27 | 2.21e-01 | -1.36e-01 | 6.69e-01 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 3.47e-01 | -1.36e-01 | 7.50e-01 |
| HEDGEHOG ON STATE | 82 | 3.48e-02 | 1.35e-01 | 3.27e-01 |
| HEDGEHOG OFF STATE | 106 | 1.67e-02 | 1.35e-01 | 2.15e-01 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 62 | 6.77e-02 | 1.34e-01 | 4.49e-01 |
| SIGNALING BY SCF KIT | 41 | 1.38e-01 | -1.34e-01 | 5.60e-01 |
| ERKS ARE INACTIVATED | 13 | 4.03e-01 | -1.34e-01 | 7.85e-01 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 4.42e-01 | -1.34e-01 | 8.00e-01 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 4.42e-01 | -1.34e-01 | 8.00e-01 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 2.55e-03 | 1.34e-01 | 5.95e-02 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 4.44e-01 | -1.33e-01 | 8.02e-01 |
| REGULATION OF TNFR1 SIGNALING | 34 | 1.80e-01 | 1.33e-01 | 6.36e-01 |
| NGF STIMULATED TRANSCRIPTION | 37 | 1.63e-01 | -1.33e-01 | 6.08e-01 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 1.64e-01 | 1.32e-01 | 6.08e-01 |
| RHO GTPASES ACTIVATE IQGAPS | 24 | 2.63e-01 | 1.32e-01 | 6.95e-01 |
| SIGNALING BY WNT IN CANCER | 31 | 2.03e-01 | -1.32e-01 | 6.52e-01 |
| ACYL CHAIN REMODELLING OF PE | 16 | 3.61e-01 | -1.32e-01 | 7.63e-01 |
| HEME BIOSYNTHESIS | 13 | 4.10e-01 | -1.32e-01 | 7.90e-01 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 46 | 1.22e-01 | 1.32e-01 | 5.56e-01 |
| HEDGEHOG LIGAND BIOGENESIS | 61 | 7.71e-02 | 1.31e-01 | 4.73e-01 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 32 | 2.01e-01 | 1.31e-01 | 6.50e-01 |
| INTERLEUKIN 6 FAMILY SIGNALING | 19 | 3.26e-01 | 1.30e-01 | 7.42e-01 |
| CELL JUNCTION ORGANIZATION | 75 | 5.14e-02 | -1.30e-01 | 4.11e-01 |
| RHOB GTPASE CYCLE | 67 | 6.63e-02 | 1.30e-01 | 4.49e-01 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 13 | 4.18e-01 | -1.30e-01 | 7.93e-01 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 3.85e-01 | 1.30e-01 | 7.74e-01 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 2.06e-01 | 1.29e-01 | 6.53e-01 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 1.30e-01 | 1.29e-01 | 5.60e-01 |
| OLFACTORY SIGNALING PATHWAY | 26 | 2.57e-01 | 1.28e-01 | 6.92e-01 |
| RNA POLYMERASE I TRANSCRIPTION | 67 | 7.08e-02 | 1.28e-01 | 4.49e-01 |
| ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 4.85e-01 | 1.28e-01 | 8.33e-01 |
| INTRA GOLGI TRAFFIC | 43 | 1.48e-01 | -1.28e-01 | 5.78e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 4.85e-01 | -1.28e-01 | 8.33e-01 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 8.83e-02 | -1.27e-01 | 4.84e-01 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 2.36e-01 | 1.27e-01 | 6.74e-01 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 57 | 9.72e-02 | -1.27e-01 | 5.04e-01 |
| CRISTAE FORMATION | 31 | 2.21e-01 | 1.27e-01 | 6.69e-01 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 29 | 2.40e-01 | -1.26e-01 | 6.77e-01 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 4.75e-02 | -1.26e-01 | 3.87e-01 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 62 | 8.80e-02 | -1.25e-01 | 4.84e-01 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 71 | 6.84e-02 | -1.25e-01 | 4.49e-01 |
| METAL ION SLC TRANSPORTERS | 24 | 2.89e-01 | -1.25e-01 | 7.05e-01 |
| RHOBTB GTPASE CYCLE | 35 | 2.03e-01 | 1.24e-01 | 6.52e-01 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.26e-01 | 1.24e-01 | 6.71e-01 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.58e-01 | -1.24e-01 | 6.92e-01 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 34 | 2.12e-01 | 1.24e-01 | 6.59e-01 |
| PHOSPHORYLATION OF THE APC C | 17 | 3.78e-01 | -1.24e-01 | 7.74e-01 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 21 | 3.28e-01 | -1.23e-01 | 7.42e-01 |
| SIGNALING BY NTRK3 TRKC | 17 | 3.79e-01 | 1.23e-01 | 7.74e-01 |
| RESOLUTION OF ABASIC SITES AP SITES | 37 | 1.95e-01 | 1.23e-01 | 6.45e-01 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 1.58e-01 | -1.23e-01 | 6.00e-01 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 175 | 5.11e-03 | -1.23e-01 | 1.05e-01 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 4.27e-01 | 1.23e-01 | 7.94e-01 |
| SIGNALING BY HEDGEHOG | 141 | 1.20e-02 | 1.23e-01 | 1.71e-01 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 4.12e-01 | 1.22e-01 | 7.90e-01 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 6.54e-02 | -1.22e-01 | 4.49e-01 |
| SIGNALING BY PDGF | 56 | 1.13e-01 | 1.22e-01 | 5.39e-01 |
| PLATELET HOMEOSTASIS | 76 | 6.57e-02 | -1.22e-01 | 4.49e-01 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 89 | 4.72e-02 | 1.22e-01 | 3.87e-01 |
| MET PROMOTES CELL MOTILITY | 39 | 1.89e-01 | 1.22e-01 | 6.43e-01 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 3.85e-01 | 1.22e-01 | 7.74e-01 |
| STRIATED MUSCLE CONTRACTION | 27 | 2.78e-01 | 1.21e-01 | 7.03e-01 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 3.08e-01 | -1.20e-01 | 7.28e-01 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 4.21e-01 | 1.20e-01 | 7.94e-01 |
| PLASMA LIPOPROTEIN REMODELING | 17 | 3.91e-01 | -1.20e-01 | 7.76e-01 |
| METHYLATION | 11 | 4.91e-01 | 1.20e-01 | 8.40e-01 |
| SIGNALING BY MET | 75 | 7.31e-02 | 1.20e-01 | 4.59e-01 |
| CILIUM ASSEMBLY | 189 | 4.61e-03 | 1.20e-01 | 9.76e-02 |
| DAP12 INTERACTIONS | 29 | 2.68e-01 | -1.19e-01 | 7.01e-01 |
| INTERLEUKIN 15 SIGNALING | 12 | 4.76e-01 | -1.19e-01 | 8.26e-01 |
| SIGNALING BY FGFR2 | 64 | 1.01e-01 | 1.19e-01 | 5.18e-01 |
| SIGNALING BY NTRK2 TRKB | 24 | 3.15e-01 | -1.19e-01 | 7.36e-01 |
| DEGRADATION OF DVL | 55 | 1.29e-01 | 1.18e-01 | 5.60e-01 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 1.36e-01 | 1.18e-01 | 5.60e-01 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 2.17e-01 | -1.17e-01 | 6.63e-01 |
| GLUCONEOGENESIS | 27 | 2.93e-01 | 1.17e-01 | 7.06e-01 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 18 | 3.91e-01 | 1.17e-01 | 7.76e-01 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 3.33e-01 | 1.17e-01 | 7.42e-01 |
| ACYL CHAIN REMODELLING OF PG | 10 | 5.23e-01 | -1.17e-01 | 8.60e-01 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 6.41e-02 | 1.16e-01 | 4.49e-01 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 43 | 1.87e-01 | -1.16e-01 | 6.43e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 2.71e-01 | 1.16e-01 | 7.02e-01 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 342 | 2.29e-04 | -1.16e-01 | 8.62e-03 |
| CARNITINE METABOLISM | 14 | 4.52e-01 | -1.16e-01 | 8.10e-01 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 10 | 5.26e-01 | -1.16e-01 | 8.60e-01 |
| SIGNALING BY CSF3 G CSF | 29 | 2.82e-01 | -1.15e-01 | 7.03e-01 |
| KINESINS | 47 | 1.72e-01 | 1.15e-01 | 6.21e-01 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 1.98e-01 | -1.15e-01 | 6.45e-01 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 25 | 3.22e-01 | -1.14e-01 | 7.41e-01 |
| EARLY PHASE OF HIV LIFE CYCLE | 14 | 4.59e-01 | -1.14e-01 | 8.11e-01 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 6.92e-02 | 1.14e-01 | 4.49e-01 |
| NRAGE SIGNALS DEATH THROUGH JNK | 56 | 1.41e-01 | 1.14e-01 | 5.65e-01 |
| RAF ACTIVATION | 34 | 2.52e-01 | -1.14e-01 | 6.88e-01 |
| PEPTIDE HORMONE METABOLISM | 59 | 1.34e-01 | -1.13e-01 | 5.60e-01 |
| CARGO CONCENTRATION IN THE ER | 31 | 2.80e-01 | -1.12e-01 | 7.03e-01 |
| NEPHRIN FAMILY INTERACTIONS | 22 | 3.64e-01 | 1.12e-01 | 7.63e-01 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 1.45e-01 | 1.12e-01 | 5.72e-01 |
| MICRORNA MIRNA BIOGENESIS | 24 | 3.45e-01 | 1.11e-01 | 7.50e-01 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 4.00e-01 | -1.11e-01 | 7.83e-01 |
| FOXO MEDIATED TRANSCRIPTION | 60 | 1.36e-01 | -1.11e-01 | 5.60e-01 |
| POTASSIUM CHANNELS | 90 | 6.87e-02 | -1.11e-01 | 4.49e-01 |
| RAC1 GTPASE CYCLE | 177 | 1.12e-02 | 1.11e-01 | 1.70e-01 |
| SLC TRANSPORTER DISORDERS | 69 | 1.12e-01 | -1.11e-01 | 5.39e-01 |
| RHOU GTPASE CYCLE | 33 | 2.72e-01 | -1.11e-01 | 7.02e-01 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 4.74e-01 | 1.10e-01 | 8.25e-01 |
| IRON UPTAKE AND TRANSPORT | 51 | 1.73e-01 | -1.10e-01 | 6.21e-01 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 3.33e-01 | -1.10e-01 | 7.42e-01 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 4.78e-01 | -1.09e-01 | 8.28e-01 |
| NEGATIVE REGULATION OF FLT3 | 14 | 4.78e-01 | 1.09e-01 | 8.28e-01 |
| HSF1 ACTIVATION | 26 | 3.35e-01 | 1.09e-01 | 7.42e-01 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 2.05e-01 | -1.09e-01 | 6.53e-01 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 3.46e-01 | 1.09e-01 | 7.50e-01 |
| NEDDYLATION | 217 | 5.82e-03 | -1.09e-01 | 1.14e-01 |
| KILLING MECHANISMS | 10 | 5.52e-01 | 1.08e-01 | 8.72e-01 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 80 | 9.36e-02 | 1.08e-01 | 4.94e-01 |
| RND1 GTPASE CYCLE | 38 | 2.48e-01 | -1.08e-01 | 6.88e-01 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 23 | 3.69e-01 | -1.08e-01 | 7.67e-01 |
| RESOLUTION OF D LOOP STRUCTURES | 30 | 3.05e-01 | -1.08e-01 | 7.26e-01 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 22 | 3.80e-01 | -1.08e-01 | 7.74e-01 |
| GAP JUNCTION DEGRADATION | 11 | 5.38e-01 | 1.07e-01 | 8.66e-01 |
| INSULIN RECEPTOR RECYCLING | 20 | 4.09e-01 | -1.07e-01 | 7.89e-01 |
| O LINKED GLYCOSYLATION | 86 | 8.77e-02 | -1.07e-01 | 4.84e-01 |
| FLT3 SIGNALING | 36 | 2.69e-01 | -1.06e-01 | 7.01e-01 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 5.43e-01 | 1.06e-01 | 8.71e-01 |
| SIGNALING BY ERBB2 IN CANCER | 25 | 3.59e-01 | -1.06e-01 | 7.62e-01 |
| EGFR DOWNREGULATION | 28 | 3.34e-01 | -1.06e-01 | 7.42e-01 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 1.50e-01 | -1.05e-01 | 5.79e-01 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 2.45e-01 | 1.05e-01 | 6.85e-01 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 4.18e-01 | -1.05e-01 | 7.93e-01 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 50 | 2.02e-01 | -1.04e-01 | 6.51e-01 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 30 | 3.25e-01 | 1.04e-01 | 7.42e-01 |
| INTERLEUKIN 7 SIGNALING | 20 | 4.23e-01 | -1.03e-01 | 7.94e-01 |
| COHESIN LOADING ONTO CHROMATIN | 10 | 5.73e-01 | 1.03e-01 | 8.80e-01 |
| G ALPHA I SIGNALLING EVENTS | 193 | 1.39e-02 | -1.03e-01 | 1.86e-01 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 4.51e-01 | -1.03e-01 | 8.10e-01 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 5.74e-01 | -1.03e-01 | 8.80e-01 |
| MEIOTIC RECOMBINATION | 38 | 2.75e-01 | -1.02e-01 | 7.03e-01 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 1.75e-01 | 1.02e-01 | 6.24e-01 |
| STABILIZATION OF P53 | 54 | 1.95e-01 | 1.02e-01 | 6.45e-01 |
| CYTOPROTECTION BY HMOX1 | 119 | 5.50e-02 | 1.02e-01 | 4.27e-01 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 4.95e-01 | 1.02e-01 | 8.44e-01 |
| BASE EXCISION REPAIR | 56 | 1.89e-01 | 1.02e-01 | 6.43e-01 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 1.37e-01 | -1.01e-01 | 5.60e-01 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 84 | 1.09e-01 | 1.01e-01 | 5.36e-01 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 45 | 2.41e-01 | 1.01e-01 | 6.77e-01 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 1.87e-01 | 1.01e-01 | 6.43e-01 |
| HCMV EARLY EVENTS | 79 | 1.21e-01 | 1.01e-01 | 5.56e-01 |
| SENSORY PROCESSING OF SOUND | 61 | 1.73e-01 | 1.01e-01 | 6.21e-01 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 5.29e-01 | 1.01e-01 | 8.61e-01 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 2.24e-01 | 1.00e-01 | 6.69e-01 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 281 | 3.90e-03 | 1.00e-01 | 8.59e-02 |
| INTEGRIN SIGNALING | 24 | 3.96e-01 | 1.00e-01 | 7.79e-01 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 12 | 5.48e-01 | -1.00e-01 | 8.71e-01 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 5.84e-01 | 1.00e-01 | 8.80e-01 |
| PEROXISOMAL PROTEIN IMPORT | 57 | 1.93e-01 | -9.98e-02 | 6.45e-01 |
| SIGNALING BY TGFB FAMILY MEMBERS | 96 | 9.58e-02 | -9.84e-02 | 4.99e-01 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 5.55e-01 | -9.84e-02 | 8.73e-01 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 4.05e-01 | -9.83e-02 | 7.85e-01 |
| SIGNALLING TO ERKS | 34 | 3.22e-01 | -9.82e-02 | 7.41e-01 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 4.71e-01 | 9.81e-02 | 8.21e-01 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 5.57e-01 | 9.80e-02 | 8.74e-01 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 149 | 3.97e-02 | 9.77e-02 | 3.54e-01 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 5.59e-01 | 9.73e-02 | 8.77e-01 |
| THE PHOTOTRANSDUCTION CASCADE | 21 | 4.41e-01 | -9.71e-02 | 8.00e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY | 13 | 5.45e-01 | -9.71e-02 | 8.71e-01 |
| SULFUR AMINO ACID METABOLISM | 22 | 4.32e-01 | 9.69e-02 | 7.94e-01 |
| RHOBTB1 GTPASE CYCLE | 23 | 4.22e-01 | 9.67e-02 | 7.94e-01 |
| INTERLEUKIN 17 SIGNALING | 66 | 1.75e-01 | -9.66e-02 | 6.24e-01 |
| PLATELET AGGREGATION PLUG FORMATION | 33 | 3.38e-01 | 9.64e-02 | 7.42e-01 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 1.90e-01 | -9.62e-02 | 6.43e-01 |
| OVARIAN TUMOR DOMAIN PROTEASES | 36 | 3.18e-01 | -9.61e-02 | 7.37e-01 |
| GLYCOGEN SYNTHESIS | 14 | 5.36e-01 | 9.56e-02 | 8.66e-01 |
| MITOTIC PROPHASE | 92 | 1.13e-01 | -9.56e-02 | 5.39e-01 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 93 | 1.13e-01 | -9.53e-02 | 5.39e-01 |
| NETRIN 1 SIGNALING | 49 | 2.49e-01 | -9.51e-02 | 6.88e-01 |
| POTENTIAL THERAPEUTICS FOR SARS | 76 | 1.53e-01 | 9.49e-02 | 5.86e-01 |
| ASSEMBLY OF THE HIV VIRION | 16 | 5.13e-01 | 9.46e-02 | 8.55e-01 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 3.87e-01 | -9.45e-02 | 7.74e-01 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 1.49e-01 | 9.44e-02 | 5.79e-01 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.96e-01 | 9.43e-02 | 6.45e-01 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 4.15e-01 | 9.42e-02 | 7.93e-01 |
| AUTOPHAGY | 138 | 5.71e-02 | 9.39e-02 | 4.34e-01 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 4.08e-01 | 9.38e-02 | 7.89e-01 |
| INWARDLY RECTIFYING K CHANNELS | 31 | 3.70e-01 | -9.30e-02 | 7.67e-01 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 4.13e-01 | 9.27e-02 | 7.92e-01 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.71e-01 | -9.27e-02 | 6.21e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 17 | 5.09e-01 | 9.26e-02 | 8.52e-01 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 4.52e-01 | -9.26e-02 | 8.10e-01 |
| NUCLEOTIDE SALVAGE | 21 | 4.64e-01 | -9.24e-02 | 8.14e-01 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 3.38e-01 | -9.24e-02 | 7.42e-01 |
| PROTEIN FOLDING | 89 | 1.33e-01 | 9.22e-02 | 5.60e-01 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 24 | 4.35e-01 | 9.22e-02 | 7.95e-01 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 12 | 5.81e-01 | -9.20e-02 | 8.80e-01 |
| BIOLOGICAL OXIDATIONS | 123 | 7.89e-02 | 9.18e-02 | 4.77e-01 |
| ZINC TRANSPORTERS | 15 | 5.39e-01 | -9.15e-02 | 8.67e-01 |
| BASE EXCISION REPAIR AP SITE FORMATION | 29 | 3.95e-01 | 9.13e-02 | 7.79e-01 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 597 | 1.52e-04 | 9.11e-02 | 6.34e-03 |
| DEGRADATION OF AXIN | 53 | 2.52e-01 | 9.10e-02 | 6.88e-01 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 5.86e-01 | 9.08e-02 | 8.80e-01 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 3.69e-01 | 9.04e-02 | 7.67e-01 |
| MEIOTIC SYNAPSIS | 39 | 3.30e-01 | 9.02e-02 | 7.42e-01 |
| INTERLEUKIN 1 FAMILY SIGNALING | 124 | 8.46e-02 | 8.98e-02 | 4.84e-01 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 4.29e-01 | -8.96e-02 | 7.94e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 17 | 5.23e-01 | -8.95e-02 | 8.60e-01 |
| SIGNALING BY NTRKS | 131 | 7.75e-02 | -8.94e-02 | 4.73e-01 |
| ABC TRANSPORTER DISORDERS | 71 | 1.93e-01 | 8.94e-02 | 6.45e-01 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 23 | 4.59e-01 | 8.93e-02 | 8.11e-01 |
| DUAL INCISION IN GG NER | 40 | 3.29e-01 | 8.93e-02 | 7.42e-01 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 4.71e-01 | 8.88e-02 | 8.21e-01 |
| SEMAPHORIN INTERACTIONS | 64 | 2.20e-01 | 8.87e-02 | 6.68e-01 |
| AURKA ACTIVATION BY TPX2 | 71 | 1.97e-01 | 8.86e-02 | 6.45e-01 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 3.28e-01 | 8.83e-02 | 7.42e-01 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 93 | 1.42e-01 | 8.81e-02 | 5.67e-01 |
| CTLA4 INHIBITORY SIGNALING | 20 | 4.98e-01 | -8.76e-02 | 8.45e-01 |
| GP1B IX V ACTIVATION SIGNALLING | 11 | 6.15e-01 | 8.75e-02 | 8.93e-01 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 5.45e-01 | -8.73e-02 | 8.71e-01 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 3.91e-01 | -8.63e-02 | 7.76e-01 |
| NICOTINAMIDE SALVAGING | 15 | 5.66e-01 | 8.57e-02 | 8.79e-01 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1209 | 8.46e-07 | -8.49e-02 | 6.58e-05 |
| MITOTIC G2 G2 M PHASES | 184 | 4.75e-02 | 8.48e-02 | 3.87e-01 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 4.55e-01 | -8.47e-02 | 8.10e-01 |
| EPHRIN SIGNALING | 19 | 5.23e-01 | -8.46e-02 | 8.60e-01 |
| POLYMERASE SWITCHING | 14 | 5.84e-01 | 8.46e-02 | 8.80e-01 |
| NERVOUS SYSTEM DEVELOPMENT | 547 | 7.57e-04 | 8.45e-02 | 2.26e-02 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 3.33e-01 | 8.44e-02 | 7.42e-01 |
| MUCOPOLYSACCHARIDOSES | 11 | 6.28e-01 | -8.44e-02 | 8.99e-01 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.03e-01 | -8.44e-02 | 8.50e-01 |
| SIGNALING BY INSULIN RECEPTOR | 61 | 2.56e-01 | -8.42e-02 | 6.90e-01 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 2.49e-01 | 8.40e-02 | 6.88e-01 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 3.77e-01 | -8.39e-02 | 7.74e-01 |
| CARDIAC CONDUCTION | 108 | 1.34e-01 | -8.36e-02 | 5.60e-01 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 50 | 3.07e-01 | -8.36e-02 | 7.28e-01 |
| CELL CELL COMMUNICATION | 107 | 1.36e-01 | -8.34e-02 | 5.60e-01 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 2.68e-01 | 8.34e-02 | 7.01e-01 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 235 | 2.94e-02 | -8.26e-02 | 2.96e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 5.81e-01 | 8.24e-02 | 8.80e-01 |
| CRMPS IN SEMA3A SIGNALING | 16 | 5.69e-01 | -8.23e-02 | 8.80e-01 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 42 | 3.59e-01 | -8.19e-02 | 7.62e-01 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 6.38e-01 | -8.19e-02 | 9.01e-01 |
| ASPARAGINE N LINKED GLYCOSYLATION | 283 | 1.84e-02 | -8.16e-02 | 2.27e-01 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 51 | 3.15e-01 | -8.14e-02 | 7.36e-01 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 5.50e-01 | -8.13e-02 | 8.71e-01 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 5.86e-01 | -8.13e-02 | 8.80e-01 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 5.31e-01 | 8.10e-02 | 8.61e-01 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 5.75e-01 | -8.09e-02 | 8.80e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 5.02e-01 | 8.08e-02 | 8.49e-01 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 4.67e-01 | -8.08e-02 | 8.19e-01 |
| TELOMERE EXTENSION BY TELOMERASE | 23 | 5.05e-01 | 8.04e-02 | 8.50e-01 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 59 | 2.88e-01 | 8.01e-02 | 7.05e-01 |
| VISUAL PHOTOTRANSDUCTION | 61 | 2.81e-01 | -7.99e-02 | 7.03e-01 |
| G1 S DNA DAMAGE CHECKPOINTS | 65 | 2.67e-01 | 7.97e-02 | 7.01e-01 |
| METABOLISM OF PORPHYRINS | 19 | 5.49e-01 | -7.95e-02 | 8.71e-01 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 60 | 2.89e-01 | 7.91e-02 | 7.05e-01 |
| DAG AND IP3 SIGNALING | 40 | 3.88e-01 | -7.90e-02 | 7.74e-01 |
| OPIOID SIGNALLING | 86 | 2.09e-01 | -7.85e-02 | 6.56e-01 |
| SHC MEDIATED CASCADE FGFR4 | 10 | 6.68e-01 | 7.83e-02 | 9.12e-01 |
| METABOLISM OF NUCLEOTIDES | 91 | 1.98e-01 | -7.82e-02 | 6.45e-01 |
| TNF SIGNALING | 43 | 3.76e-01 | 7.81e-02 | 7.72e-01 |
| RECYCLING PATHWAY OF L1 | 40 | 3.94e-01 | 7.79e-02 | 7.79e-01 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 74 | 2.49e-01 | 7.75e-02 | 6.88e-01 |
| SYNTHESIS OF PC | 25 | 5.05e-01 | 7.70e-02 | 8.50e-01 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 108 | 1.67e-01 | 7.70e-02 | 6.10e-01 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 2.95e-01 | 7.70e-02 | 7.08e-01 |
| REGULATION OF FZD BY UBIQUITINATION | 19 | 5.61e-01 | -7.70e-02 | 8.78e-01 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 94 | 1.97e-01 | -7.70e-02 | 6.45e-01 |
| SIGNALING BY FGFR | 74 | 2.53e-01 | 7.69e-02 | 6.88e-01 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 3.94e-01 | 7.69e-02 | 7.79e-01 |
| NEURONAL SYSTEM | 363 | 1.27e-02 | -7.64e-02 | 1.76e-01 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 6.22e-01 | -7.62e-02 | 8.93e-01 |
| PCP CE PATHWAY | 90 | 2.13e-01 | 7.60e-02 | 6.59e-01 |
| HDMS DEMETHYLATE HISTONES | 27 | 4.94e-01 | -7.60e-02 | 8.44e-01 |
| DSCAM INTERACTIONS | 11 | 6.63e-01 | -7.58e-02 | 9.12e-01 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 36 | 4.32e-01 | -7.57e-02 | 7.94e-01 |
| ADAPTIVE IMMUNE SYSTEM | 599 | 1.62e-03 | -7.57e-02 | 4.20e-02 |
| DISEASES OF METABOLISM | 199 | 6.59e-02 | 7.57e-02 | 4.49e-01 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 4.59e-01 | 7.56e-02 | 8.11e-01 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 169 | 9.04e-02 | -7.56e-02 | 4.86e-01 |
| RHOV GTPASE CYCLE | 32 | 4.60e-01 | -7.55e-02 | 8.11e-01 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 5.70e-01 | -7.54e-02 | 8.80e-01 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 4.85e-01 | -7.50e-02 | 8.33e-01 |
| CD209 DC SIGN SIGNALING | 18 | 5.83e-01 | -7.48e-02 | 8.80e-01 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 133 | 1.37e-01 | -7.47e-02 | 5.60e-01 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 89 | 2.23e-01 | 7.47e-02 | 6.69e-01 |
| IRS MEDIATED SIGNALLING | 37 | 4.32e-01 | -7.46e-02 | 7.94e-01 |
| CELLULAR RESPONSE TO HYPOXIA | 71 | 2.80e-01 | 7.42e-02 | 7.03e-01 |
| PTEN REGULATION | 134 | 1.39e-01 | 7.42e-02 | 5.62e-01 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 5.86e-01 | 7.41e-02 | 8.80e-01 |
| BASIGIN INTERACTIONS | 22 | 5.47e-01 | -7.41e-02 | 8.71e-01 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 6.20e-01 | -7.40e-02 | 8.93e-01 |
| INTRAFLAGELLAR TRANSPORT | 49 | 3.71e-01 | 7.40e-02 | 7.67e-01 |
| SIGNALING BY NOTCH2 | 33 | 4.63e-01 | -7.39e-02 | 8.14e-01 |
| ENOS ACTIVATION | 11 | 6.73e-01 | -7.36e-02 | 9.12e-01 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 59 | 3.28e-01 | 7.36e-02 | 7.42e-01 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 5.90e-01 | -7.34e-02 | 8.83e-01 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 21 | 5.61e-01 | 7.34e-02 | 8.78e-01 |
| INTERLEUKIN 20 FAMILY SIGNALING | 14 | 6.36e-01 | 7.31e-02 | 9.01e-01 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 5.45e-01 | 7.29e-02 | 8.71e-01 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 87 | 2.41e-01 | -7.28e-02 | 6.77e-01 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 6.77e-01 | 7.26e-02 | 9.13e-01 |
| ION HOMEOSTASIS | 48 | 3.85e-01 | -7.25e-02 | 7.74e-01 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 5.31e-01 | 7.23e-02 | 8.61e-01 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 3.58e-01 | 7.23e-02 | 7.62e-01 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 5.01e-01 | -7.22e-02 | 8.49e-01 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 4.60e-01 | 7.21e-02 | 8.11e-01 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 13 | 6.53e-01 | 7.20e-02 | 9.12e-01 |
| G1 S SPECIFIC TRANSCRIPTION | 26 | 5.26e-01 | -7.18e-02 | 8.60e-01 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 6.67e-01 | 7.18e-02 | 9.12e-01 |
| METABOLISM OF POLYAMINES | 57 | 3.50e-01 | 7.16e-02 | 7.50e-01 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 5.12e-01 | 7.16e-02 | 8.55e-01 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 4.46e-01 | 7.15e-02 | 8.04e-01 |
| RHOG GTPASE CYCLE | 73 | 2.91e-01 | 7.15e-02 | 7.05e-01 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 14 | 6.47e-01 | -7.08e-02 | 9.06e-01 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 21 | 5.75e-01 | -7.07e-02 | 8.80e-01 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 5.95e-01 | -7.05e-02 | 8.86e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 6.37e-01 | 7.04e-02 | 9.01e-01 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 3.63e-01 | -7.03e-02 | 7.63e-01 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 5.06e-01 | -7.02e-02 | 8.51e-01 |
| ESR MEDIATED SIGNALING | 163 | 1.25e-01 | -6.97e-02 | 5.56e-01 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 4.96e-01 | -6.95e-02 | 8.44e-01 |
| G ALPHA 12 13 SIGNALLING EVENTS | 75 | 2.99e-01 | 6.93e-02 | 7.16e-01 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 6.91e-01 | 6.93e-02 | 9.17e-01 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 4.33e-01 | -6.91e-02 | 7.94e-01 |
| PI METABOLISM | 79 | 2.90e-01 | -6.90e-02 | 7.05e-01 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 21 | 5.86e-01 | -6.86e-02 | 8.80e-01 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 63 | 3.46e-01 | 6.86e-02 | 7.50e-01 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 5.30e-01 | -6.85e-02 | 8.61e-01 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 90 | 2.64e-01 | -6.81e-02 | 6.98e-01 |
| TP53 REGULATES METABOLIC GENES | 84 | 2.85e-01 | -6.76e-02 | 7.03e-01 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 103 | 2.38e-01 | 6.74e-02 | 6.75e-01 |
| MITOTIC PROMETAPHASE | 175 | 1.25e-01 | 6.72e-02 | 5.56e-01 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 50 | 4.11e-01 | 6.72e-02 | 7.90e-01 |
| G PROTEIN MEDIATED EVENTS | 52 | 4.02e-01 | -6.72e-02 | 7.85e-01 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 6.43e-01 | 6.69e-02 | 9.03e-01 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 6.34e-01 | -6.68e-02 | 9.01e-01 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 20 | 6.06e-01 | 6.67e-02 | 8.89e-01 |
| INTERLEUKIN 35 SIGNALLING | 10 | 7.15e-01 | 6.66e-02 | 9.24e-01 |
| SHC MEDIATED CASCADE FGFR1 | 15 | 6.57e-01 | 6.63e-02 | 9.12e-01 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 11 | 7.04e-01 | 6.63e-02 | 9.22e-01 |
| UCH PROTEINASES | 88 | 2.86e-01 | 6.59e-02 | 7.04e-01 |
| S PHASE | 153 | 1.60e-01 | -6.58e-02 | 6.02e-01 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 6.81e-01 | 6.58e-02 | 9.13e-01 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 6.94e-01 | 6.57e-02 | 9.18e-01 |
| INTERLEUKIN 2 FAMILY SIGNALING | 33 | 5.14e-01 | 6.56e-02 | 8.55e-01 |
| NICOTINATE METABOLISM | 24 | 5.78e-01 | 6.56e-02 | 8.80e-01 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 95 | 2.71e-01 | 6.53e-02 | 7.02e-01 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 4.21e-01 | -6.51e-02 | 7.94e-01 |
| GLYCOSAMINOGLYCAN METABOLISM | 114 | 2.32e-01 | -6.49e-02 | 6.72e-01 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 7.11e-01 | -6.45e-02 | 9.24e-01 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 26 | 5.70e-01 | -6.44e-02 | 8.80e-01 |
| DEVELOPMENTAL BIOLOGY | 811 | 2.12e-03 | 6.39e-02 | 5.11e-02 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 43 | 4.70e-01 | -6.37e-02 | 8.21e-01 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 47 | 4.50e-01 | 6.36e-02 | 8.10e-01 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 70 | 3.60e-01 | 6.33e-02 | 7.62e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 176 | 1.49e-01 | 6.31e-02 | 5.79e-01 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 65 | 3.81e-01 | 6.29e-02 | 7.74e-01 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 35 | 5.21e-01 | -6.27e-02 | 8.60e-01 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 3.80e-01 | 6.25e-02 | 7.74e-01 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 38 | 5.08e-01 | 6.20e-02 | 8.52e-01 |
| OTHER INTERLEUKIN SIGNALING | 20 | 6.32e-01 | 6.19e-02 | 9.00e-01 |
| SIGNALING BY RETINOIC ACID | 33 | 5.38e-01 | -6.19e-02 | 8.66e-01 |
| HCMV INFECTION | 102 | 2.81e-01 | 6.18e-02 | 7.03e-01 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 5.54e-01 | 6.15e-02 | 8.73e-01 |
| GLUCAGON TYPE LIGAND RECEPTORS | 23 | 6.11e-01 | -6.14e-02 | 8.93e-01 |
| SARS COV 1 INFECTION | 48 | 4.64e-01 | 6.11e-02 | 8.14e-01 |
| RHOQ GTPASE CYCLE | 58 | 4.22e-01 | 6.10e-02 | 7.94e-01 |
| SIGNALLING TO RAS | 20 | 6.37e-01 | 6.10e-02 | 9.01e-01 |
| INTERLEUKIN 1 SIGNALING | 95 | 3.05e-01 | 6.09e-02 | 7.26e-01 |
| NONHOMOLOGOUS END JOINING NHEJ | 43 | 4.90e-01 | -6.09e-02 | 8.40e-01 |
| G2 M CHECKPOINTS | 133 | 2.29e-01 | -6.05e-02 | 6.72e-01 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 6.49e-01 | 6.04e-02 | 9.08e-01 |
| GLUTATHIONE CONJUGATION | 29 | 5.75e-01 | 6.02e-02 | 8.80e-01 |
| LAGGING STRAND SYNTHESIS | 20 | 6.42e-01 | 6.01e-02 | 9.02e-01 |
| HOMOLOGY DIRECTED REPAIR | 107 | 2.84e-01 | -6.00e-02 | 7.03e-01 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 6.98e-01 | 5.99e-02 | 9.21e-01 |
| PI3K AKT SIGNALING IN CANCER | 89 | 3.31e-01 | -5.97e-02 | 7.42e-01 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 16 | 6.80e-01 | -5.96e-02 | 9.13e-01 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 5.66e-01 | -5.96e-02 | 8.79e-01 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 4.55e-01 | -5.93e-02 | 8.10e-01 |
| VLDLR INTERNALISATION AND DEGRADATION | 12 | 7.23e-01 | -5.92e-02 | 9.27e-01 |
| CHROMATIN MODIFYING ENZYMES | 217 | 1.34e-01 | 5.91e-02 | 5.60e-01 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 18 | 6.67e-01 | 5.85e-02 | 9.12e-01 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 70 | 3.98e-01 | -5.85e-02 | 7.82e-01 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 7.37e-01 | 5.84e-02 | 9.35e-01 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 24 | 6.21e-01 | 5.84e-02 | 8.93e-01 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 6.21e-01 | 5.84e-02 | 8.93e-01 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 21 | 6.44e-01 | 5.83e-02 | 9.03e-01 |
| MITOCHONDRIAL BIOGENESIS | 92 | 3.34e-01 | 5.83e-02 | 7.42e-01 |
| INOSITOL PHOSPHATE METABOLISM | 47 | 4.90e-01 | 5.82e-02 | 8.40e-01 |
| SIGNAL AMPLIFICATION | 30 | 5.82e-01 | -5.81e-02 | 8.80e-01 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 62 | 4.31e-01 | -5.79e-02 | 7.94e-01 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 3.60e-01 | 5.79e-02 | 7.62e-01 |
| PARASITE INFECTION | 55 | 4.60e-01 | -5.76e-02 | 8.11e-01 |
| TRIGLYCERIDE CATABOLISM | 14 | 7.11e-01 | -5.72e-02 | 9.24e-01 |
| SEPARATION OF SISTER CHROMATIDS | 165 | 2.06e-01 | 5.72e-02 | 6.53e-01 |
| RESOLUTION OF SISTER CHROMATID COHESION | 100 | 3.25e-01 | 5.70e-02 | 7.42e-01 |
| GPCR LIGAND BINDING | 261 | 1.17e-01 | -5.65e-02 | 5.50e-01 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 140 | 2.55e-01 | -5.58e-02 | 6.90e-01 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 5.75e-01 | -5.55e-02 | 8.80e-01 |
| RHO GTPASE CYCLE | 427 | 5.05e-02 | 5.54e-02 | 4.06e-01 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 82 | 3.87e-01 | 5.53e-02 | 7.74e-01 |
| RAS PROCESSING | 24 | 6.39e-01 | 5.53e-02 | 9.01e-01 |
| SIGNALING BY FGFR3 | 34 | 5.78e-01 | 5.51e-02 | 8.80e-01 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 628 | 1.90e-02 | 5.51e-02 | 2.27e-01 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 69 | 4.32e-01 | -5.48e-02 | 7.94e-01 |
| ARACHIDONIC ACID METABOLISM | 40 | 5.51e-01 | 5.45e-02 | 8.71e-01 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 6.73e-01 | 5.45e-02 | 9.12e-01 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 180 | 2.10e-01 | -5.42e-02 | 6.59e-01 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 6.14e-01 | 5.42e-02 | 8.93e-01 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 4.37e-01 | 5.42e-02 | 7.96e-01 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 7.18e-01 | 5.39e-02 | 9.24e-01 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 6.56e-01 | 5.37e-02 | 9.12e-01 |
| HS GAG BIOSYNTHESIS | 29 | 6.18e-01 | -5.35e-02 | 8.93e-01 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 21 | 6.72e-01 | -5.35e-02 | 9.12e-01 |
| GENERATION OF SECOND MESSENGER MOLECULES | 20 | 6.79e-01 | 5.34e-02 | 9.13e-01 |
| DNA REPAIR | 291 | 1.18e-01 | -5.33e-02 | 5.54e-01 |
| REGULATION OF RAS BY GAPS | 66 | 4.54e-01 | 5.33e-02 | 8.10e-01 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 43 | 5.46e-01 | -5.33e-02 | 8.71e-01 |
| GABA B RECEPTOR ACTIVATION | 39 | 5.65e-01 | -5.32e-02 | 8.79e-01 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 6.81e-01 | -5.31e-02 | 9.13e-01 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 7.22e-01 | -5.30e-02 | 9.27e-01 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 6.82e-01 | -5.30e-02 | 9.13e-01 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 5.77e-01 | -5.30e-02 | 8.80e-01 |
| NUCLEAR ENVELOPE BREAKDOWN | 47 | 5.31e-01 | -5.29e-02 | 8.61e-01 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 24 | 6.54e-01 | -5.28e-02 | 9.12e-01 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 30 | 6.17e-01 | -5.28e-02 | 8.93e-01 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 7.63e-01 | 5.25e-02 | 9.45e-01 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 31 | 6.13e-01 | -5.25e-02 | 8.93e-01 |
| SYNTHESIS OF PA | 29 | 6.26e-01 | 5.23e-02 | 8.97e-01 |
| PLASMA LIPOPROTEIN CLEARANCE | 27 | 6.41e-01 | 5.19e-02 | 9.02e-01 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 6.17e-01 | 5.19e-02 | 8.93e-01 |
| HIV TRANSCRIPTION ELONGATION | 42 | 5.62e-01 | 5.17e-02 | 8.78e-01 |
| SUMOYLATION | 162 | 2.58e-01 | -5.15e-02 | 6.92e-01 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 117 | 3.36e-01 | 5.15e-02 | 7.42e-01 |
| PYROPTOSIS | 20 | 6.91e-01 | -5.14e-02 | 9.17e-01 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 4.23e-01 | 5.12e-02 | 7.94e-01 |
| FCERI MEDIATED NF KB ACTIVATION | 76 | 4.41e-01 | 5.11e-02 | 8.00e-01 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 25 | 6.59e-01 | 5.10e-02 | 9.12e-01 |
| MYOGENESIS | 25 | 6.59e-01 | -5.09e-02 | 9.12e-01 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 6.19e-01 | 5.08e-02 | 8.93e-01 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 12 | 7.61e-01 | 5.07e-02 | 9.45e-01 |
| NOD1 2 SIGNALING PATHWAY | 35 | 6.04e-01 | 5.07e-02 | 8.89e-01 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 82 | 4.28e-01 | -5.07e-02 | 7.94e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 92 | 4.05e-01 | 5.03e-02 | 7.85e-01 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 7.37e-01 | -5.02e-02 | 9.35e-01 |
| DISEASES OF PROGRAMMED CELL DEATH | 54 | 5.25e-01 | 5.01e-02 | 8.60e-01 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 95 | 3.99e-01 | 5.01e-02 | 7.83e-01 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.06e-01 | -5.00e-02 | 9.22e-01 |
| MAPK6 MAPK4 SIGNALING | 83 | 4.32e-01 | 4.99e-02 | 7.94e-01 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 4.10e-01 | -4.98e-02 | 7.90e-01 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 42 | 5.78e-01 | -4.97e-02 | 8.80e-01 |
| PLATELET SENSITIZATION BY LDL | 15 | 7.39e-01 | 4.96e-02 | 9.35e-01 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 5.84e-01 | 4.95e-02 | 8.80e-01 |
| MITOTIC METAPHASE AND ANAPHASE | 205 | 2.27e-01 | 4.90e-02 | 6.71e-01 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 4.36e-01 | -4.89e-02 | 7.96e-01 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 7.14e-01 | 4.86e-02 | 9.24e-01 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 4.24e-01 | -4.85e-02 | 7.94e-01 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 6.36e-01 | -4.84e-02 | 9.01e-01 |
| RNA POLYMERASE II TRANSCRIPTION | 1084 | 7.84e-03 | -4.82e-02 | 1.32e-01 |
| REGULATION OF BACH1 ACTIVITY | 11 | 7.82e-01 | -4.81e-02 | 9.50e-01 |
| PHASE 2 PLATEAU PHASE | 13 | 7.64e-01 | -4.81e-02 | 9.45e-01 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 7.74e-01 | 4.78e-02 | 9.48e-01 |
| SIGNALING BY GPCR | 478 | 7.42e-02 | -4.78e-02 | 4.63e-01 |
| MTORC1 MEDIATED SIGNALLING | 24 | 6.87e-01 | 4.76e-02 | 9.17e-01 |
| NEGATIVE REGULATION OF MET ACTIVITY | 21 | 7.07e-01 | -4.74e-02 | 9.22e-01 |
| DNA REPLICATION | 121 | 3.68e-01 | -4.74e-02 | 7.67e-01 |
| HCMV LATE EVENTS | 64 | 5.13e-01 | -4.73e-02 | 8.55e-01 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 7.96e-01 | 4.73e-02 | 9.53e-01 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 4.00e-01 | -4.69e-02 | 7.83e-01 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 6.17e-01 | 4.69e-02 | 8.93e-01 |
| TRANSPORT OF SMALL MOLECULES | 568 | 5.77e-02 | -4.68e-02 | 4.34e-01 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 7.11e-01 | -4.68e-02 | 9.24e-01 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 7.46e-01 | 4.67e-02 | 9.40e-01 |
| METALLOPROTEASE DUBS | 25 | 6.86e-01 | -4.67e-02 | 9.17e-01 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 59 | 5.35e-01 | 4.67e-02 | 8.66e-01 |
| PRC2 METHYLATES HISTONES AND DNA | 29 | 6.66e-01 | 4.64e-02 | 9.12e-01 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 7.56e-01 | -4.63e-02 | 9.43e-01 |
| HYALURONAN UPTAKE AND DEGRADATION | 11 | 7.91e-01 | -4.63e-02 | 9.53e-01 |
| RAB REGULATION OF TRAFFICKING | 118 | 3.87e-01 | -4.62e-02 | 7.74e-01 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 7.02e-01 | 4.61e-02 | 9.22e-01 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 6.01e-01 | 4.61e-02 | 8.89e-01 |
| PI 3K CASCADE FGFR2 | 16 | 7.49e-01 | 4.61e-02 | 9.40e-01 |
| DEATH RECEPTOR SIGNALLING | 134 | 3.59e-01 | 4.60e-02 | 7.62e-01 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 141 | 3.48e-01 | -4.58e-02 | 7.50e-01 |
| RHO GTPASE EFFECTORS | 247 | 2.16e-01 | 4.58e-02 | 6.63e-01 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 7.93e-01 | -4.57e-02 | 9.53e-01 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 6.81e-01 | 4.57e-02 | 9.13e-01 |
| APOPTOTIC EXECUTION PHASE | 45 | 5.96e-01 | -4.57e-02 | 8.86e-01 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 21 | 7.17e-01 | -4.56e-02 | 9.24e-01 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 7.31e-01 | 4.55e-02 | 9.33e-01 |
| SARS COV 2 INFECTION | 65 | 5.26e-01 | -4.55e-02 | 8.60e-01 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 7.39e-01 | 4.54e-02 | 9.35e-01 |
| PI 3K CASCADE FGFR4 | 10 | 8.04e-01 | 4.54e-02 | 9.55e-01 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 5.24e-01 | 4.50e-02 | 8.60e-01 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 6.92e-01 | 4.48e-02 | 9.18e-01 |
| DNA STRAND ELONGATION | 32 | 6.62e-01 | -4.47e-02 | 9.12e-01 |
| LYSOSOME VESICLE BIOGENESIS | 33 | 6.58e-01 | 4.45e-02 | 9.12e-01 |
| SIGNALING BY LEPTIN | 10 | 8.08e-01 | 4.43e-02 | 9.56e-01 |
| PI 3K CASCADE FGFR1 | 15 | 7.67e-01 | 4.43e-02 | 9.45e-01 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 540 | 8.02e-02 | -4.42e-02 | 4.80e-01 |
| NUCLEAR SIGNALING BY ERBB4 | 31 | 6.71e-01 | 4.41e-02 | 9.12e-01 |
| SIGNALING BY NUCLEAR RECEPTORS | 220 | 2.61e-01 | -4.41e-02 | 6.95e-01 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 6.63e-01 | 4.38e-02 | 9.12e-01 |
| METABOLISM OF COFACTORS | 18 | 7.48e-01 | 4.37e-02 | 9.40e-01 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 28 | 6.90e-01 | 4.36e-02 | 9.17e-01 |
| FANCONI ANEMIA PATHWAY | 36 | 6.53e-01 | 4.33e-02 | 9.12e-01 |
| STIMULI SENSING CHANNELS | 74 | 5.20e-01 | -4.32e-02 | 8.60e-01 |
| G ALPHA Z SIGNALLING EVENTS | 45 | 6.16e-01 | -4.32e-02 | 8.93e-01 |
| TRIGLYCERIDE METABOLISM | 22 | 7.27e-01 | -4.30e-02 | 9.29e-01 |
| SIGNALING BY PTK6 | 50 | 5.99e-01 | 4.29e-02 | 8.89e-01 |
| L1CAM INTERACTIONS | 109 | 4.40e-01 | 4.28e-02 | 8.00e-01 |
| PEROXISOMAL LIPID METABOLISM | 26 | 7.06e-01 | -4.28e-02 | 9.22e-01 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 5.90e-01 | 4.24e-02 | 8.83e-01 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 7.50e-01 | 4.23e-02 | 9.40e-01 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 51 | 6.01e-01 | -4.23e-02 | 8.89e-01 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 7.04e-01 | -4.23e-02 | 9.22e-01 |
| INFECTIOUS DISEASE | 727 | 5.38e-02 | 4.22e-02 | 4.24e-01 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 8.00e-01 | -4.22e-02 | 9.54e-01 |
| LDL CLEARANCE | 16 | 7.72e-01 | 4.18e-02 | 9.48e-01 |
| MEMBRANE TRAFFICKING | 579 | 8.77e-02 | -4.17e-02 | 4.84e-01 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 108 | 4.54e-01 | 4.17e-02 | 8.10e-01 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 21 | 7.41e-01 | -4.17e-02 | 9.36e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 7.95e-01 | -4.16e-02 | 9.53e-01 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 35 | 6.71e-01 | 4.15e-02 | 9.12e-01 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 5.95e-01 | -4.15e-02 | 8.86e-01 |
| TCR SIGNALING | 102 | 4.70e-01 | 4.15e-02 | 8.21e-01 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 3.42e-01 | 4.14e-02 | 7.48e-01 |
| DOWNREGULATION OF ERBB2 SIGNALING | 28 | 7.05e-01 | 4.14e-02 | 9.22e-01 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 6.72e-01 | -4.13e-02 | 9.12e-01 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 28 | 7.10e-01 | -4.06e-02 | 9.24e-01 |
| RHOH GTPASE CYCLE | 37 | 6.69e-01 | -4.06e-02 | 9.12e-01 |
| G ALPHA S SIGNALLING EVENTS | 103 | 4.79e-01 | -4.04e-02 | 8.28e-01 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 7.80e-01 | 4.03e-02 | 9.50e-01 |
| RAC2 GTPASE CYCLE | 86 | 5.21e-01 | 4.01e-02 | 8.60e-01 |
| CELL CYCLE CHECKPOINTS | 241 | 2.85e-01 | -4.01e-02 | 7.03e-01 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 6.31e-01 | -4.00e-02 | 9.00e-01 |
| INFLAMMASOMES | 19 | 7.64e-01 | -3.99e-02 | 9.45e-01 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 6.88e-01 | -3.98e-02 | 9.17e-01 |
| SIGNALING BY ERBB4 | 57 | 6.04e-01 | -3.97e-02 | 8.89e-01 |
| RNA POLYMERASE I PROMOTER ESCAPE | 47 | 6.38e-01 | 3.96e-02 | 9.01e-01 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 13 | 8.05e-01 | -3.96e-02 | 9.55e-01 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 86 | 5.28e-01 | -3.94e-02 | 8.61e-01 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 12 | 8.13e-01 | 3.94e-02 | 9.58e-01 |
| SIGNALING BY NOTCH4 | 83 | 5.37e-01 | 3.92e-02 | 8.66e-01 |
| MYD88 INDEPENDENT TLR4 CASCADE | 93 | 5.14e-01 | -3.91e-02 | 8.55e-01 |
| DNA DOUBLE STRAND BREAK REPAIR | 136 | 4.32e-01 | -3.91e-02 | 7.94e-01 |
| EPH EPHRIN SIGNALING | 90 | 5.22e-01 | -3.90e-02 | 8.60e-01 |
| SENSORY PERCEPTION | 146 | 4.16e-01 | 3.90e-02 | 7.93e-01 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 8.32e-01 | -3.88e-02 | 9.68e-01 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 183 | 3.70e-01 | -3.85e-02 | 7.67e-01 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 226 | 3.20e-01 | 3.84e-02 | 7.40e-01 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 7.87e-01 | 3.79e-02 | 9.52e-01 |
| REGULATION OF SIGNALING BY CBL | 22 | 7.62e-01 | 3.73e-02 | 9.45e-01 |
| RHOF GTPASE CYCLE | 40 | 6.84e-01 | -3.72e-02 | 9.15e-01 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 81 | 5.66e-01 | 3.69e-02 | 8.79e-01 |
| RHO GTPASES ACTIVATE FORMINS | 118 | 4.92e-01 | 3.67e-02 | 8.40e-01 |
| PD 1 SIGNALING | 10 | 8.42e-01 | 3.64e-02 | 9.69e-01 |
| HYALURONAN METABOLISM | 15 | 8.08e-01 | -3.62e-02 | 9.56e-01 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 13 | 8.21e-01 | -3.62e-02 | 9.63e-01 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 17 | 7.97e-01 | -3.61e-02 | 9.53e-01 |
| DNA REPLICATION PRE INITIATION | 79 | 5.83e-01 | -3.58e-02 | 8.80e-01 |
| SIGNALING BY NOTCH1 | 75 | 5.93e-01 | 3.57e-02 | 8.85e-01 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 31 | 7.33e-01 | -3.54e-02 | 9.33e-01 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 7.18e-01 | -3.53e-02 | 9.24e-01 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 7.56e-01 | -3.52e-02 | 9.43e-01 |
| REPRODUCTION | 75 | 6.01e-01 | 3.49e-02 | 8.89e-01 |
| ION CHANNEL TRANSPORT | 138 | 4.81e-01 | -3.48e-02 | 8.30e-01 |
| MAPK FAMILY SIGNALING CASCADES | 288 | 3.12e-01 | 3.47e-02 | 7.33e-01 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 32 | 7.35e-01 | 3.45e-02 | 9.35e-01 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 7.80e-01 | -3.45e-02 | 9.50e-01 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 76 | 6.05e-01 | -3.43e-02 | 8.89e-01 |
| REGULATION OF BETA CELL DEVELOPMENT | 24 | 7.71e-01 | -3.43e-02 | 9.48e-01 |
| NEUREXINS AND NEUROLIGINS | 54 | 6.64e-01 | 3.42e-02 | 9.12e-01 |
| HATS ACETYLATE HISTONES | 91 | 5.74e-01 | -3.41e-02 | 8.80e-01 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 6.71e-01 | -3.40e-02 | 9.12e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 6.94e-01 | -3.39e-02 | 9.18e-01 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 8.33e-01 | 3.38e-02 | 9.68e-01 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 10 | 8.55e-01 | 3.35e-02 | 9.73e-01 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 7.59e-01 | -3.34e-02 | 9.45e-01 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 7.82e-01 | 3.34e-02 | 9.50e-01 |
| FRS MEDIATED FGFR2 SIGNALING | 18 | 8.07e-01 | 3.33e-02 | 9.56e-01 |
| SIGNALING BY NOTCH | 188 | 4.34e-01 | 3.31e-02 | 7.95e-01 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 7.66e-01 | 3.31e-02 | 9.45e-01 |
| NUCLEOTIDE EXCISION REPAIR | 109 | 5.55e-01 | -3.28e-02 | 8.73e-01 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 53 | 6.80e-01 | 3.28e-02 | 9.13e-01 |
| EXTENSION OF TELOMERES | 50 | 6.91e-01 | 3.26e-02 | 9.17e-01 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 6.56e-01 | -3.25e-02 | 9.12e-01 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 42 | 7.18e-01 | -3.22e-02 | 9.24e-01 |
| G PROTEIN ACTIVATION | 22 | 7.96e-01 | -3.19e-02 | 9.53e-01 |
| TBC RABGAPS | 43 | 7.18e-01 | -3.19e-02 | 9.24e-01 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 8.29e-01 | -3.11e-02 | 9.68e-01 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 83 | 6.26e-01 | -3.10e-02 | 8.97e-01 |
| FRS MEDIATED FGFR1 SIGNALING | 17 | 8.26e-01 | 3.09e-02 | 9.67e-01 |
| SIGNALING BY INTERLEUKINS | 348 | 3.26e-01 | 3.07e-02 | 7.42e-01 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 31 | 7.68e-01 | -3.06e-02 | 9.45e-01 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 8.49e-01 | 3.05e-02 | 9.72e-01 |
| PROLACTIN RECEPTOR SIGNALING | 11 | 8.61e-01 | -3.05e-02 | 9.73e-01 |
| DNA METHYLATION | 20 | 8.13e-01 | 3.05e-02 | 9.58e-01 |
| GLYCOSPHINGOLIPID METABOLISM | 38 | 7.47e-01 | -3.02e-02 | 9.40e-01 |
| NUCLEOBASE CATABOLISM | 31 | 7.72e-01 | -3.01e-02 | 9.48e-01 |
| SYNTHESIS OF PE | 12 | 8.57e-01 | -3.00e-02 | 9.73e-01 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 29 | 7.80e-01 | 3.00e-02 | 9.50e-01 |
| TOLL LIKE RECEPTOR CASCADES | 137 | 5.47e-01 | -2.98e-02 | 8.71e-01 |
| CIRCADIAN CLOCK | 68 | 6.76e-01 | -2.94e-02 | 9.13e-01 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 8.12e-01 | -2.92e-02 | 9.58e-01 |
| VESICLE MEDIATED TRANSPORT | 608 | 2.25e-01 | -2.90e-02 | 6.69e-01 |
| INTERLEUKIN 12 FAMILY SIGNALING | 44 | 7.40e-01 | 2.89e-02 | 9.35e-01 |
| CLEC7A DECTIN 1 SIGNALING | 94 | 6.30e-01 | 2.88e-02 | 9.00e-01 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 15 | 8.47e-01 | -2.87e-02 | 9.72e-01 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 6.05e-01 | -2.86e-02 | 8.89e-01 |
| METABOLISM OF VITAMINS AND COFACTORS | 150 | 5.50e-01 | 2.83e-02 | 8.71e-01 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 12 | 8.65e-01 | 2.83e-02 | 9.73e-01 |
| SIGNALING BY FGFR IN DISEASE | 55 | 7.17e-01 | 2.83e-02 | 9.24e-01 |
| LEISHMANIA INFECTION | 193 | 5.02e-01 | -2.81e-02 | 8.49e-01 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 7.98e-01 | 2.80e-02 | 9.53e-01 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 8.57e-01 | 2.78e-02 | 9.73e-01 |
| M PHASE | 337 | 3.83e-01 | 2.77e-02 | 7.74e-01 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 78 | 6.72e-01 | 2.77e-02 | 9.12e-01 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 13 | 8.64e-01 | 2.74e-02 | 9.73e-01 |
| SIGNALING BY FGFR4 | 31 | 7.93e-01 | 2.73e-02 | 9.53e-01 |
| TRNA PROCESSING | 105 | 6.30e-01 | 2.72e-02 | 9.00e-01 |
| TRP CHANNELS | 19 | 8.37e-01 | -2.72e-02 | 9.69e-01 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 8.82e-01 | 2.71e-02 | 9.77e-01 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 7.49e-01 | 2.67e-02 | 9.40e-01 |
| RA BIOSYNTHESIS PATHWAY | 13 | 8.68e-01 | -2.67e-02 | 9.73e-01 |
| SARS COV INFECTIONS | 139 | 5.90e-01 | 2.65e-02 | 8.83e-01 |
| MAP2K AND MAPK ACTIVATION | 36 | 7.85e-01 | 2.63e-02 | 9.52e-01 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 8.27e-01 | 2.63e-02 | 9.68e-01 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 8.04e-01 | 2.62e-02 | 9.55e-01 |
| FRS MEDIATED FGFR4 SIGNALING | 12 | 8.75e-01 | 2.62e-02 | 9.77e-01 |
| DISEASES OF GLYCOSYLATION | 125 | 6.14e-01 | 2.62e-02 | 8.93e-01 |
| TRAF6 MEDIATED NF KB ACTIVATION | 22 | 8.35e-01 | -2.56e-02 | 9.68e-01 |
| REGULATION OF TP53 ACTIVITY | 148 | 5.92e-01 | 2.56e-02 | 8.84e-01 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 8.89e-01 | 2.55e-02 | 9.77e-01 |
| CELLULAR RESPONSE TO HEAT STRESS | 95 | 6.70e-01 | 2.53e-02 | 9.12e-01 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 24 | 8.33e-01 | -2.49e-02 | 9.68e-01 |
| MTOR SIGNALLING | 40 | 7.86e-01 | -2.48e-02 | 9.52e-01 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 7.32e-01 | -2.47e-02 | 9.33e-01 |
| HIV TRANSCRIPTION INITIATION | 45 | 7.74e-01 | -2.47e-02 | 9.48e-01 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 23 | 8.38e-01 | -2.47e-02 | 9.69e-01 |
| NEUTROPHIL DEGRANULATION | 383 | 4.17e-01 | 2.42e-02 | 7.93e-01 |
| CHROMOSOME MAINTENANCE | 103 | 6.71e-01 | 2.42e-02 | 9.12e-01 |
| FATTY ACID METABOLISM | 146 | 6.14e-01 | 2.42e-02 | 8.93e-01 |
| RAC3 GTPASE CYCLE | 88 | 6.95e-01 | -2.42e-02 | 9.19e-01 |
| HEMOSTASIS | 472 | 3.71e-01 | 2.41e-02 | 7.67e-01 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 13 | 8.81e-01 | -2.41e-02 | 9.77e-01 |
| IRAK4 DEFICIENCY TLR2 4 | 12 | 8.87e-01 | 2.38e-02 | 9.77e-01 |
| AQUAPORIN MEDIATED TRANSPORT | 40 | 7.95e-01 | -2.37e-02 | 9.53e-01 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 8.51e-01 | -2.36e-02 | 9.72e-01 |
| ACYL CHAIN REMODELLING OF PC | 17 | 8.67e-01 | 2.35e-02 | 9.73e-01 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 8.94e-01 | 2.32e-02 | 9.77e-01 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 61 | 7.54e-01 | -2.32e-02 | 9.42e-01 |
| HIV LIFE CYCLE | 143 | 6.38e-01 | 2.28e-02 | 9.01e-01 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 14 | 8.82e-01 | 2.28e-02 | 9.77e-01 |
| ION TRANSPORT BY P TYPE ATPASES | 47 | 7.89e-01 | -2.25e-02 | 9.53e-01 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 8.88e-01 | -2.25e-02 | 9.77e-01 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 8.40e-01 | 2.24e-02 | 9.69e-01 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 8.66e-01 | 2.23e-02 | 9.73e-01 |
| NEUROTRANSMITTER RELEASE CYCLE | 48 | 7.89e-01 | 2.23e-02 | 9.53e-01 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 100 | 7.01e-01 | 2.22e-02 | 9.22e-01 |
| INTERLEUKIN 6 SIGNALING | 10 | 9.03e-01 | -2.22e-02 | 9.77e-01 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 63 | 7.61e-01 | -2.22e-02 | 9.45e-01 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 184 | 6.05e-01 | -2.21e-02 | 8.89e-01 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 8.21e-01 | 2.21e-02 | 9.63e-01 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 84 | 7.30e-01 | 2.18e-02 | 9.32e-01 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 8.36e-01 | -2.15e-02 | 9.68e-01 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 8.78e-01 | 2.15e-02 | 9.77e-01 |
| AMYLOID FIBER FORMATION | 57 | 7.81e-01 | -2.13e-02 | 9.50e-01 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 81 | 7.43e-01 | 2.11e-02 | 9.38e-01 |
| GAB1 SIGNALOSOME | 14 | 8.92e-01 | 2.10e-02 | 9.77e-01 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 7.53e-01 | -2.09e-02 | 9.42e-01 |
| ONCOGENE INDUCED SENESCENCE | 32 | 8.39e-01 | -2.08e-02 | 9.69e-01 |
| C TYPE LECTIN RECEPTORS CLRS | 112 | 7.04e-01 | 2.08e-02 | 9.22e-01 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 7.81e-01 | -2.07e-02 | 9.50e-01 |
| SURFACTANT METABOLISM | 16 | 8.87e-01 | 2.06e-02 | 9.77e-01 |
| G0 AND EARLY G1 | 24 | 8.63e-01 | -2.04e-02 | 9.73e-01 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 26 | 8.57e-01 | 2.04e-02 | 9.73e-01 |
| PEPTIDE LIGAND BINDING RECEPTORS | 103 | 7.25e-01 | -2.01e-02 | 9.28e-01 |
| PECAM1 INTERACTIONS | 12 | 9.07e-01 | 1.94e-02 | 9.77e-01 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 34 | 8.46e-01 | -1.93e-02 | 9.72e-01 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 12 | 9.08e-01 | -1.92e-02 | 9.77e-01 |
| MEIOSIS | 63 | 7.93e-01 | -1.91e-02 | 9.53e-01 |
| INTERLEUKIN 12 SIGNALING | 37 | 8.41e-01 | -1.90e-02 | 9.69e-01 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 14 | 9.02e-01 | 1.90e-02 | 9.77e-01 |
| METABOLISM OF LIPIDS | 611 | 4.28e-01 | -1.89e-02 | 7.94e-01 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 8.82e-01 | 1.88e-02 | 9.77e-01 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 123 | 7.21e-01 | -1.87e-02 | 9.26e-01 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 9.07e-01 | -1.86e-02 | 9.77e-01 |
| MITOTIC SPINDLE CHECKPOINT | 96 | 7.53e-01 | -1.86e-02 | 9.42e-01 |
| REGULATED NECROSIS | 45 | 8.31e-01 | -1.84e-02 | 9.68e-01 |
| PKMTS METHYLATE HISTONE LYSINES | 48 | 8.26e-01 | 1.83e-02 | 9.67e-01 |
| PERK REGULATES GENE EXPRESSION | 28 | 8.67e-01 | -1.82e-02 | 9.73e-01 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 20 | 8.88e-01 | -1.82e-02 | 9.77e-01 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 9.00e-01 | 1.81e-02 | 9.77e-01 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 8.40e-01 | -1.80e-02 | 9.69e-01 |
| METABOLISM OF CARBOHYDRATES | 258 | 6.20e-01 | -1.80e-02 | 8.93e-01 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 8.58e-01 | 1.79e-02 | 9.73e-01 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 9.11e-01 | -1.79e-02 | 9.78e-01 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 21 | 8.88e-01 | 1.77e-02 | 9.77e-01 |
| INTEGRATION OF ENERGY METABOLISM | 98 | 7.67e-01 | 1.73e-02 | 9.45e-01 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 9.02e-01 | -1.73e-02 | 9.77e-01 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 8.54e-01 | -1.73e-02 | 9.73e-01 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 8.18e-01 | -1.70e-02 | 9.62e-01 |
| MISMATCH REPAIR | 14 | 9.13e-01 | 1.69e-02 | 9.79e-01 |
| HS GAG DEGRADATION | 20 | 8.97e-01 | -1.68e-02 | 9.77e-01 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 85 | 7.97e-01 | -1.61e-02 | 9.53e-01 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 27 | 8.85e-01 | -1.60e-02 | 9.77e-01 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 8.81e-01 | -1.60e-02 | 9.77e-01 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 33 | 8.77e-01 | 1.56e-02 | 9.77e-01 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 21 | 9.04e-01 | 1.52e-02 | 9.77e-01 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 100 | 7.99e-01 | -1.48e-02 | 9.53e-01 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 8.94e-01 | 1.43e-02 | 9.77e-01 |
| INNATE IMMUNE SYSTEM | 772 | 5.07e-01 | 1.41e-02 | 8.51e-01 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 8.35e-01 | 1.40e-02 | 9.68e-01 |
| KERATAN SULFATE BIOSYNTHESIS | 24 | 9.08e-01 | -1.37e-02 | 9.77e-01 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 35 | 8.89e-01 | -1.36e-02 | 9.77e-01 |
| DEUBIQUITINATION | 241 | 7.18e-01 | -1.35e-02 | 9.24e-01 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 9.15e-01 | 1.34e-02 | 9.80e-01 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 66 | 8.53e-01 | 1.32e-02 | 9.73e-01 |
| GOLGI TO ER RETROGRADE TRANSPORT | 118 | 8.05e-01 | -1.32e-02 | 9.55e-01 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 29 | 9.02e-01 | -1.32e-02 | 9.77e-01 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 9.40e-01 | 1.31e-02 | 9.84e-01 |
| SIGNALING BY FGFR2 IN DISEASE | 36 | 8.93e-01 | 1.30e-02 | 9.77e-01 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 114 | 8.11e-01 | -1.30e-02 | 9.57e-01 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 8.63e-01 | 1.30e-02 | 9.73e-01 |
| SPHINGOLIPID METABOLISM | 79 | 8.46e-01 | -1.27e-02 | 9.72e-01 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 9.35e-01 | -1.25e-02 | 9.83e-01 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 9.04e-01 | 1.25e-02 | 9.77e-01 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 9.43e-01 | 1.25e-02 | 9.84e-01 |
| TIE2 SIGNALING | 17 | 9.29e-01 | 1.25e-02 | 9.83e-01 |
| SIGNALING BY VEGF | 102 | 8.30e-01 | 1.23e-02 | 9.68e-01 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 9.25e-01 | -1.22e-02 | 9.83e-01 |
| GENE SILENCING BY RNA | 84 | 8.50e-01 | -1.20e-02 | 9.72e-01 |
| REGULATION OF INSULIN SECRETION | 71 | 8.62e-01 | -1.20e-02 | 9.73e-01 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 22 | 9.23e-01 | 1.19e-02 | 9.83e-01 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 8.80e-01 | -1.16e-02 | 9.77e-01 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 77 | 8.60e-01 | -1.16e-02 | 9.73e-01 |
| MUSCLE CONTRACTION | 163 | 8.01e-01 | 1.15e-02 | 9.54e-01 |
| SIGNALING BY ERBB2 | 48 | 8.91e-01 | -1.14e-02 | 9.77e-01 |
| RND3 GTPASE CYCLE | 38 | 9.03e-01 | -1.14e-02 | 9.77e-01 |
| RHOJ GTPASE CYCLE | 54 | 8.89e-01 | 1.10e-02 | 9.77e-01 |
| PROTEIN LOCALIZATION | 156 | 8.14e-01 | -1.09e-02 | 9.58e-01 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 8.50e-01 | -1.08e-02 | 9.72e-01 |
| SIGNALING BY EGFR | 47 | 8.98e-01 | 1.08e-02 | 9.77e-01 |
| DUAL INCISION IN TC NER | 64 | 8.83e-01 | -1.07e-02 | 9.77e-01 |
| SNRNP ASSEMBLY | 51 | 8.97e-01 | -1.05e-02 | 9.77e-01 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 24 | 9.30e-01 | -1.04e-02 | 9.83e-01 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 464 | 7.03e-01 | 1.04e-02 | 9.22e-01 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 9.38e-01 | 1.03e-02 | 9.84e-01 |
| RHOD GTPASE CYCLE | 50 | 9.04e-01 | 9.81e-03 | 9.77e-01 |
| MRNA CAPPING | 29 | 9.29e-01 | 9.62e-03 | 9.83e-01 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 8.84e-01 | 9.58e-03 | 9.77e-01 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 9.33e-01 | 9.55e-03 | 9.83e-01 |
| CELL CYCLE MITOTIC | 471 | 7.24e-01 | 9.54e-03 | 9.27e-01 |
| P38MAPK EVENTS | 13 | 9.53e-01 | 9.47e-03 | 9.84e-01 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 338 | 7.67e-01 | -9.41e-03 | 9.45e-01 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 140 | 8.51e-01 | -9.23e-03 | 9.72e-01 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 9.55e-01 | 9.04e-03 | 9.84e-01 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 52 | 9.11e-01 | 8.97e-03 | 9.78e-01 |
| ONCOGENIC MAPK SIGNALING | 77 | 8.93e-01 | -8.86e-03 | 9.77e-01 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 9.29e-01 | -8.80e-03 | 9.83e-01 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 366 | 7.78e-01 | -8.59e-03 | 9.50e-01 |
| SIGNALING BY NOTCH3 | 48 | 9.19e-01 | 8.50e-03 | 9.82e-01 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 9.44e-01 | 8.10e-03 | 9.84e-01 |
| ASPARTATE AND ASPARAGINE METABOLISM | 10 | 9.65e-01 | 8.05e-03 | 9.87e-01 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 9.55e-01 | -7.68e-03 | 9.84e-01 |
| GLUCOSE METABOLISM | 80 | 9.06e-01 | 7.61e-03 | 9.77e-01 |
| SIGNALING BY FGFR1 IN DISEASE | 32 | 9.41e-01 | 7.53e-03 | 9.84e-01 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 9.36e-01 | 7.22e-03 | 9.83e-01 |
| HIV INFECTION | 221 | 8.59e-01 | 6.93e-03 | 9.73e-01 |
| DNA DOUBLE STRAND BREAK RESPONSE | 52 | 9.33e-01 | 6.79e-03 | 9.83e-01 |
| PRE NOTCH EXPRESSION AND PROCESSING | 63 | 9.27e-01 | 6.66e-03 | 9.83e-01 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 9.70e-01 | 6.66e-03 | 9.87e-01 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 9.44e-01 | 6.64e-03 | 9.84e-01 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 9.56e-01 | -6.60e-03 | 9.84e-01 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 9.55e-01 | 6.41e-03 | 9.84e-01 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 9.67e-01 | 6.18e-03 | 9.87e-01 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 9.20e-01 | -6.09e-03 | 9.82e-01 |
| GLYCOLYSIS | 66 | 9.34e-01 | -5.90e-03 | 9.83e-01 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 9.61e-01 | -5.89e-03 | 9.85e-01 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 35 | 9.52e-01 | 5.83e-03 | 9.84e-01 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 9.26e-01 | -5.73e-03 | 9.83e-01 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 9.45e-01 | 5.72e-03 | 9.84e-01 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 9.70e-01 | -5.68e-03 | 9.87e-01 |
| MHC CLASS II ANTIGEN PRESENTATION | 103 | 9.21e-01 | 5.66e-03 | 9.82e-01 |
| FLT3 SIGNALING IN DISEASE | 27 | 9.61e-01 | -5.51e-03 | 9.85e-01 |
| RND2 GTPASE CYCLE | 38 | 9.54e-01 | 5.45e-03 | 9.84e-01 |
| SIGNALING BY FGFR1 | 43 | 9.51e-01 | -5.41e-03 | 9.84e-01 |
| RET SIGNALING | 37 | 9.56e-01 | -5.24e-03 | 9.84e-01 |
| CELLULAR SENESCENCE | 140 | 9.16e-01 | 5.17e-03 | 9.80e-01 |
| PHASE II CONJUGATION OF COMPOUNDS | 60 | 9.45e-01 | 5.11e-03 | 9.84e-01 |
| HOST INTERACTIONS OF HIV FACTORS | 125 | 9.24e-01 | -4.94e-03 | 9.83e-01 |
| UB SPECIFIC PROCESSING PROTEASES | 167 | 9.14e-01 | -4.87e-03 | 9.79e-01 |
| RHO GTPASES ACTIVATE PKNS | 47 | 9.54e-01 | -4.84e-03 | 9.84e-01 |
| ORC1 REMOVAL FROM CHROMATIN | 67 | 9.46e-01 | -4.80e-03 | 9.84e-01 |
| KERATAN SULFATE KERATIN METABOLISM | 30 | 9.64e-01 | 4.74e-03 | 9.87e-01 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 9.77e-01 | 4.62e-03 | 9.91e-01 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 9.68e-01 | -4.49e-03 | 9.87e-01 |
| METABOLISM OF STEROIDS | 112 | 9.35e-01 | 4.47e-03 | 9.83e-01 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 9.60e-01 | -4.46e-03 | 9.85e-01 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 9.01e-01 | 4.32e-03 | 9.77e-01 |
| TELOMERE MAINTENANCE | 79 | 9.48e-01 | 4.25e-03 | 9.84e-01 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 9.58e-01 | -4.25e-03 | 9.85e-01 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 9.49e-01 | 4.23e-03 | 9.84e-01 |
| SIGNALING BY NODAL | 15 | 9.79e-01 | 3.94e-03 | 9.91e-01 |
| APOPTOSIS | 162 | 9.34e-01 | 3.79e-03 | 9.83e-01 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 9.78e-01 | -3.73e-03 | 9.91e-01 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 9.68e-01 | 3.67e-03 | 9.87e-01 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 9.77e-01 | -3.65e-03 | 9.91e-01 |
| PHOSPHOLIPID METABOLISM | 186 | 9.32e-01 | -3.61e-03 | 9.83e-01 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 138 | 9.43e-01 | 3.52e-03 | 9.84e-01 |
| FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 9.86e-01 | -3.25e-03 | 9.94e-01 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 17 | 9.82e-01 | 3.22e-03 | 9.92e-01 |
| METABOLISM OF STEROID HORMONES | 20 | 9.80e-01 | 3.20e-03 | 9.91e-01 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 42 | 9.76e-01 | -2.70e-03 | 9.91e-01 |
| SIGNALING BY EGFR IN CANCER | 22 | 9.85e-01 | 2.29e-03 | 9.94e-01 |
| PROTEIN METHYLATION | 17 | 9.88e-01 | -2.12e-03 | 9.94e-01 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 62 | 9.79e-01 | 1.97e-03 | 9.91e-01 |
| SIGNALING BY WNT | 266 | 9.60e-01 | -1.77e-03 | 9.85e-01 |
| PURINE SALVAGE | 12 | 9.92e-01 | -1.64e-03 | 9.96e-01 |
| CELL CYCLE | 589 | 9.47e-01 | 1.59e-03 | 9.84e-01 |
| PROGRAMMED CELL DEATH | 184 | 9.71e-01 | -1.54e-03 | 9.88e-01 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 32 | 9.88e-01 | 1.51e-03 | 9.94e-01 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 9.90e-01 | -1.44e-03 | 9.96e-01 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 9.87e-01 | -1.39e-03 | 9.94e-01 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 14 | 9.93e-01 | 1.26e-03 | 9.96e-01 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 27 | 9.92e-01 | 1.06e-03 | 9.96e-01 |
| FCERI MEDIATED CA 2 MOBILIZATION | 26 | 9.96e-01 | 5.64e-04 | 9.97e-01 |
| G ALPHA Q SIGNALLING EVENTS | 156 | 9.96e-01 | -2.31e-04 | 9.97e-01 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 1.00e+00 | -1.55e-05 | 1.00e+00 |
MET ACTIVATES RAP1 AND RAC1
| 534 | |
|---|---|
| set | MET ACTIVATES RAP1 AND RAC1 |
| setSize | 11 |
| pANOVA | 0.00104 |
| s.dist | -0.571 |
| p.adjustANOVA | 0.0296 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rap1b | -8382 |
| Met | -7793 |
| Hgf | -7787 |
| Rac1 | -7094 |
| Dock7 | -6822 |
| Crkl | -5515 |
| Rap1a | -5254 |
| Crk | -5197 |
| Gab1 | -4850 |
| Grb2 | -3233 |
| Rapgef1 | 4681 |
| GeneID | Gene Rank |
|---|---|
| Rap1b | -8382 |
| Met | -7793 |
| Hgf | -7787 |
| Rac1 | -7094 |
| Dock7 | -6822 |
| Crkl | -5515 |
| Rap1a | -5254 |
| Crk | -5197 |
| Gab1 | -4850 |
| Grb2 | -3233 |
| Rapgef1 | 4681 |
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
| 1039 | |
|---|---|
| set | SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE |
| setSize | 11 |
| pANOVA | 0.00215 |
| s.dist | -0.534 |
| p.adjustANOVA | 0.0511 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pikfyve | -8077 |
| Pik3c2a | -7961 |
| Mtmr2 | -7642 |
| Pik3c3 | -6280 |
| Mtmr9 | -5965 |
| Mtmr7 | -5768 |
| Mtmr4 | -5613 |
| Fig4 | -4289 |
| Pik3r4 | -3300 |
| Mtm1 | 393 |
| Vac14 | 638 |
| GeneID | Gene Rank |
|---|---|
| Pikfyve | -8077 |
| Pik3c2a | -7961 |
| Mtmr2 | -7642 |
| Pik3c3 | -6280 |
| Mtmr9 | -5965 |
| Mtmr7 | -5768 |
| Mtmr4 | -5613 |
| Fig4 | -4289 |
| Pik3r4 | -3300 |
| Mtm1 | 393 |
| Vac14 | 638 |
ACTIVATION OF RAC1
| 24 | |
|---|---|
| set | ACTIVATION OF RAC1 |
| setSize | 13 |
| pANOVA | 0.00176 |
| s.dist | -0.501 |
| p.adjustANOVA | 0.0448 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Slit2 | -8763 |
| Pak1 | -7266 |
| Robo1 | -7152 |
| Rac1 | -7094 |
| Sos2 | -6283 |
| Sos1 | -5957 |
| Pak5 | -5255 |
| Pak3 | -3689 |
| Pak6 | -2724 |
| Pak2 | -2269 |
| Pak4 | -1910 |
| Nck2 | -1100 |
| Nck1 | -530 |
| GeneID | Gene Rank |
|---|---|
| Slit2 | -8763 |
| Pak1 | -7266 |
| Robo1 | -7152 |
| Rac1 | -7094 |
| Sos2 | -6283 |
| Sos1 | -5957 |
| Pak5 | -5255 |
| Pak3 | -3689 |
| Pak6 | -2724 |
| Pak2 | -2269 |
| Pak4 | -1910 |
| Nck2 | -1100 |
| Nck1 | -530 |
INITIAL TRIGGERING OF COMPLEMENT
| 443 | |
|---|---|
| set | INITIAL TRIGGERING OF COMPLEMENT |
| setSize | 10 |
| pANOVA | 0.01 |
| s.dist | 0.47 |
| p.adjustANOVA | 0.154 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C2 | 7830 |
| Cfp | 7752 |
| C1qb | 6966 |
| Masp2 | 5994 |
| C4b | 4905 |
| C1qc | 4382 |
| C1qa | 3001 |
| Masp1 | 2826 |
| Gzmm | -547 |
| Cfb | -7716 |
| GeneID | Gene Rank |
|---|---|
| C2 | 7830 |
| Cfp | 7752 |
| C1qb | 6966 |
| Masp2 | 5994 |
| C4b | 4905 |
| C1qc | 4382 |
| C1qa | 3001 |
| Masp1 | 2826 |
| Gzmm | -547 |
| Cfb | -7716 |
CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
| 199 | |
|---|---|
| set | CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY |
| setSize | 13 |
| pANOVA | 0.00633 |
| s.dist | 0.437 |
| p.adjustANOVA | 0.115 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ercc2 | 7653 |
| Ciao2b | 7479 |
| Ndor1 | 7409 |
| Pold1 | 6726 |
| Ciapin1 | 5074 |
| Ciao3 | 5063 |
| Rtel1 | 4820 |
| Brip1 | 4238 |
| Nubp1 | 3460 |
| Abcb7 | -1266 |
| Mms19 | -1589 |
| Nubp2 | -3102 |
| Ciao1 | -3545 |
| GeneID | Gene Rank |
|---|---|
| Ercc2 | 7653 |
| Ciao2b | 7479 |
| Ndor1 | 7409 |
| Pold1 | 6726 |
| Ciapin1 | 5074 |
| Ciao3 | 5063 |
| Rtel1 | 4820 |
| Brip1 | 4238 |
| Nubp1 | 3460 |
| Abcb7 | -1266 |
| Mms19 | -1589 |
| Nubp2 | -3102 |
| Ciao1 | -3545 |
EUKARYOTIC TRANSLATION ELONGATION
| 301 | |
|---|---|
| set | EUKARYOTIC TRANSLATION ELONGATION |
| setSize | 87 |
| pANOVA | 1.86e-12 |
| s.dist | 0.437 |
| p.adjustANOVA | 2.18e-09 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Eef1d | 6824 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Eef1a2 | 6277 |
| Rpl35 | 6264 |
| Eef2 | 6157 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Eef1d | 6824 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Eef1a2 | 6277 |
| Rpl35 | 6264 |
| Eef2 | 6157 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| Rpl6 | 5381 |
| Rps18 | 5259 |
| Rpl8 | 5182 |
| Rps27l | 4781 |
| Rpl35a | 4749 |
| Eef1g | 4670 |
| Rplp1 | 4497 |
| Rpl7a | 4489 |
| Rpl24 | 4485 |
| Rps25 | 4349 |
| Rps3a1 | 4211 |
| Rpl14 | 4027 |
| Rpl32 | 4021 |
| Rpl13 | 3983 |
| Rps17 | 3940 |
| Rps11 | 3934 |
| Rpl18a | 3929 |
| Uba52 | 3876 |
| Rpl12 | 3790 |
| Rpl10 | 3755 |
| Rps6 | 3747 |
| Fau | 3714 |
| Rpl30 | 3435 |
| Rps16 | 3425 |
| Rpl31 | 3267 |
| Rps14 | 3149 |
| Rps24 | 3077 |
| Rps15 | 3027 |
| Rpl21 | 3024 |
| Rps10 | 2979 |
| Rpl27a | 2892 |
| Eef1b2 | 2808 |
| Rpl36al | 2751 |
| Rps7 | 2731 |
| Rpl19 | 2668 |
| Rpl3 | 2654 |
| Rpsa | 2614 |
| Rpl36 | 2443 |
| Rpl11 | 2320 |
| Rps5 | 2249 |
| Rpl18 | 1869 |
| Rps27 | 1669 |
| Rpl9 | 1493 |
| Rpl5 | 1297 |
| Rps12 | 1217 |
| Rpl36a | 927 |
| Rpl10a | 895 |
| Rpl4 | 873 |
| Rps23 | 872 |
| Rpl22 | 732 |
| Rpl27 | 529 |
| Rpl13a | 406 |
| Rps20 | -240 |
| Rplp0 | -309 |
| Rpl29 | -312 |
| Rpl34 | -373 |
| Rps3 | -775 |
| Rpl7 | -1359 |
| Rps15a | -1947 |
| Rpl39 | -2430 |
| Rpl17 | -2699 |
| Eef1a1 | -2849 |
| Rpl15 | -3330 |
| Rpl22l1 | -3372 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
| 185 | |
|---|---|
| set | CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE |
| setSize | 11 |
| pANOVA | 0.0122 |
| s.dist | -0.437 |
| p.adjustANOVA | 0.171 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Prkacb | -8544 |
| Prkar2b | -8346 |
| Prkar1a | -7991 |
| Creb1 | -7647 |
| Prkx | -7158 |
| Calm1 | -6803 |
| Adcy1 | -4571 |
| Prkar1b | -546 |
| Adcy8 | 661 |
| Prkaca | 1782 |
| Prkar2a | 4341 |
| GeneID | Gene Rank |
|---|---|
| Prkacb | -8544 |
| Prkar2b | -8346 |
| Prkar1a | -7991 |
| Creb1 | -7647 |
| Prkx | -7158 |
| Calm1 | -6803 |
| Adcy1 | -4571 |
| Prkar1b | -546 |
| Adcy8 | 661 |
| Prkaca | 1782 |
| Prkar2a | 4341 |
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
| 621 | |
|---|---|
| set | NF KB IS ACTIVATED AND SIGNALS SURVIVAL |
| setSize | 13 |
| pANOVA | 0.00681 |
| s.dist | 0.433 |
| p.adjustANOVA | 0.122 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ikbkb | 6593 |
| Nfkb1 | 6575 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Nfkbia | 2118 |
| Sqstm1 | 727 |
| Rela | 29 |
| Traf6 | -3825 |
| GeneID | Gene Rank |
|---|---|
| Ikbkb | 6593 |
| Nfkb1 | 6575 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Nfkbia | 2118 |
| Sqstm1 | 727 |
| Rela | 29 |
| Traf6 | -3825 |
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON
| 20 | |
|---|---|
| set | ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON |
| setSize | 16 |
| pANOVA | 0.00278 |
| s.dist | 0.432 |
| p.adjustANOVA | 0.0636 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Irf3 | 7213 |
| Ticam2 | 6835 |
| Cd14 | 6545 |
| Rps27a | 5852 |
| Ikbke | 4960 |
| Ptpn11 | 4357 |
| Ticam1 | 4298 |
| Tlr4 | 3893 |
| Uba52 | 3876 |
| Traf3 | 3513 |
| Ubc | 3089 |
| Tank | 2755 |
| Ubb | 2615 |
| Tbk1 | 643 |
| Sarm1 | -166 |
| Irf7 | -8811 |
| GeneID | Gene Rank |
|---|---|
| Irf3 | 7213 |
| Ticam2 | 6835 |
| Cd14 | 6545 |
| Rps27a | 5852 |
| Ikbke | 4960 |
| Ptpn11 | 4357 |
| Ticam1 | 4298 |
| Tlr4 | 3893 |
| Uba52 | 3876 |
| Traf3 | 3513 |
| Ubc | 3089 |
| Tank | 2755 |
| Ubb | 2615 |
| Tbk1 | 643 |
| Sarm1 | -166 |
| Irf7 | -8811 |
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
| 909 | |
|---|---|
| set | SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE |
| setSize | 20 |
| pANOVA | 0.000909 |
| s.dist | 0.428 |
| p.adjustANOVA | 0.0265 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Plxnb1 | 6902 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rhoc | 5770 |
| Rnd1 | 5407 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Arhgef11 | 2057 |
| Erbb2 | 8 |
| Sema4d | -257 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Arhgef12 | -2059 |
| Rhoa | -3484 |
| Rhob | -5010 |
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Plxnb1 | 6902 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rhoc | 5770 |
| Rnd1 | 5407 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Arhgef11 | 2057 |
| Erbb2 | 8 |
| Sema4d | -257 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Arhgef12 | -2059 |
| Rhoa | -3484 |
| Rhob | -5010 |
SCAVENGING BY CLASS A RECEPTORS
| 901 | |
|---|---|
| set | SCAVENGING BY CLASS A RECEPTORS |
| setSize | 14 |
| pANOVA | 0.00755 |
| s.dist | 0.412 |
| p.adjustANOVA | 0.131 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Calr | 7889 |
| Col1a2 | 7492 |
| Colec12 | 7328 |
| Apoe | 6023 |
| Col3a1 | 5984 |
| Col4a2 | 5670 |
| Masp1 | 2826 |
| Col1a1 | 2599 |
| Hsp90b1 | 2547 |
| Ftl1 | 1744 |
| Apoa1 | -74 |
| Fth1 | -278 |
| Col4a1 | -844 |
| Scara5 | -6165 |
| GeneID | Gene Rank |
|---|---|
| Calr | 7889 |
| Col1a2 | 7492 |
| Colec12 | 7328 |
| Apoe | 6023 |
| Col3a1 | 5984 |
| Col4a2 | 5670 |
| Masp1 | 2826 |
| Col1a1 | 2599 |
| Hsp90b1 | 2547 |
| Ftl1 | 1744 |
| Apoa1 | -74 |
| Fth1 | -278 |
| Col4a1 | -844 |
| Scara5 | -6165 |
SEROTONIN RECEPTORS
| 917 | |
|---|---|
| set | SEROTONIN RECEPTORS |
| setSize | 10 |
| pANOVA | 0.0292 |
| s.dist | -0.398 |
| p.adjustANOVA | 0.296 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Htr4 | -8729 |
| Htr5a | -7227 |
| Htr2a | -7180 |
| Htr2c | -6735 |
| Htr1d | -5086 |
| Htr6 | -2887 |
| Htr1f | -2717 |
| Htr1a | 57 |
| Htr1b | 1192 |
| Htr7 | 1775 |
| GeneID | Gene Rank |
|---|---|
| Htr4 | -8729 |
| Htr5a | -7227 |
| Htr2a | -7180 |
| Htr2c | -6735 |
| Htr1d | -5086 |
| Htr6 | -2887 |
| Htr1f | -2717 |
| Htr1a | 57 |
| Htr1b | 1192 |
| Htr7 | 1775 |
COLLAGEN CHAIN TRIMERIZATION
| 164 | |
|---|---|
| set | COLLAGEN CHAIN TRIMERIZATION |
| setSize | 40 |
| pANOVA | 1.46e-05 |
| s.dist | 0.396 |
| p.adjustANOVA | 0.000812 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Col4a2 | 5670 |
| Col28a1 | 4763 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Col9a3 | 3789 |
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Col4a2 | 5670 |
| Col28a1 | 4763 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Col9a3 | 3789 |
| Col18a1 | 3050 |
| Col24a1 | 2997 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col17a1 | 2390 |
| Col6a5 | 2356 |
| Col20a1 | 1863 |
| Col4a3 | 1850 |
| Col11a1 | 1221 |
| Col14a1 | -449 |
| Col19a1 | -590 |
| Col8a1 | -758 |
| Col4a1 | -844 |
| Col5a1 | -939 |
| Col23a1 | -3675 |
| Col9a1 | -4500 |
| Col6a6 | -5128 |
| Col25a1 | -5179 |
| Col22a1 | -5346 |
| Col8a2 | -7555 |
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
| 1037 | |
|---|---|
| set | SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE |
| setSize | 16 |
| pANOVA | 0.00615 |
| s.dist | -0.396 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pikfyve | -8077 |
| Pik3c2a | -7961 |
| Mtmr2 | -7642 |
| Pik3c3 | -6280 |
| Mtmr12 | -5786 |
| Mtmr4 | -5613 |
| Fig4 | -4289 |
| Inpp5f | -4102 |
| Inpp4a | -3940 |
| Pi4k2b | -3897 |
| Pik3r4 | -3300 |
| Mtmr10 | -1072 |
| Mtm1 | 393 |
| Inpp4b | 582 |
| Vac14 | 638 |
| Pi4k2a | 669 |
| GeneID | Gene Rank |
|---|---|
| Pikfyve | -8077 |
| Pik3c2a | -7961 |
| Mtmr2 | -7642 |
| Pik3c3 | -6280 |
| Mtmr12 | -5786 |
| Mtmr4 | -5613 |
| Fig4 | -4289 |
| Inpp5f | -4102 |
| Inpp4a | -3940 |
| Pi4k2b | -3897 |
| Pik3r4 | -3300 |
| Mtmr10 | -1072 |
| Mtm1 | 393 |
| Inpp4b | 582 |
| Vac14 | 638 |
| Pi4k2a | 669 |
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
| 798 | |
|---|---|
| set | REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA |
| setSize | 13 |
| pANOVA | 0.0189 |
| s.dist | 0.376 |
| p.adjustANOVA | 0.227 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Irf3 | 7213 |
| Rps27a | 5852 |
| Sting1 | 5286 |
| Ddx41 | 4210 |
| Uba52 | 3876 |
| Dtx4 | 3119 |
| Ubc | 3089 |
| Ubb | 2615 |
| Trim56 | 1619 |
| Tbk1 | 643 |
| Trim32 | -53 |
| Trex1 | -238 |
| Trim21 | -1495 |
| GeneID | Gene Rank |
|---|---|
| Irf3 | 7213 |
| Rps27a | 5852 |
| Sting1 | 5286 |
| Ddx41 | 4210 |
| Uba52 | 3876 |
| Dtx4 | 3119 |
| Ubc | 3089 |
| Ubb | 2615 |
| Trim56 | 1619 |
| Tbk1 | 643 |
| Trim32 | -53 |
| Trex1 | -238 |
| Trim21 | -1495 |
RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
| 833 | |
|---|---|
| set | RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY |
| setSize | 94 |
| pANOVA | 3.75e-10 |
| s.dist | 0.374 |
| p.adjustANOVA | 7.95e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ddit3 | 7639 |
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Gcn1 | 6172 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| GeneID | Gene Rank |
|---|---|
| Ddit3 | 7639 |
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Gcn1 | 6172 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| Rpl6 | 5381 |
| Rps18 | 5259 |
| Rpl8 | 5182 |
| Rps27l | 4781 |
| Rpl35a | 4749 |
| Rplp1 | 4497 |
| Rpl7a | 4489 |
| Rpl24 | 4485 |
| Rps25 | 4349 |
| Rps3a1 | 4211 |
| Rpl14 | 4027 |
| Rpl32 | 4021 |
| Rpl13 | 3983 |
| Rps17 | 3940 |
| Rps11 | 3934 |
| Rpl18a | 3929 |
| Uba52 | 3876 |
| Atf4 | 3827 |
| Rpl12 | 3790 |
| Rpl10 | 3755 |
| Rps6 | 3747 |
| Fau | 3714 |
| Rpl30 | 3435 |
| Rps16 | 3425 |
| Rpl31 | 3267 |
| Rps14 | 3149 |
| Rps24 | 3077 |
| Rps15 | 3027 |
| Rpl21 | 3024 |
| Rps10 | 2979 |
| Rpl27a | 2892 |
| Rpl36al | 2751 |
| Rps7 | 2731 |
| Rpl19 | 2668 |
| Rpl3 | 2654 |
| Atf3 | 2633 |
| Rpsa | 2614 |
| Rpl36 | 2443 |
| Rpl11 | 2320 |
| Rps5 | 2249 |
| Rpl18 | 1869 |
| Rps27 | 1669 |
| Rpl9 | 1493 |
| Rpl5 | 1297 |
| Rps12 | 1217 |
| Rpl36a | 927 |
| Rpl10a | 895 |
| Impact | 879 |
| Rpl4 | 873 |
| Rps23 | 872 |
| Eif2ak4 | 840 |
| Rpl22 | 732 |
| Rpl27 | 529 |
| Rpl13a | 406 |
| Rps20 | -240 |
| Rplp0 | -309 |
| Rpl29 | -312 |
| Rpl34 | -373 |
| Rps3 | -775 |
| Eif2s1 | -1087 |
| Rpl7 | -1359 |
| Eif2s2 | -1396 |
| Cebpg | -1746 |
| Eif2s3x | -1929 |
| Rps15a | -1947 |
| Rpl39 | -2430 |
| Rpl17 | -2699 |
| Rpl15 | -3330 |
| Rpl22l1 | -3372 |
| Cebpb | -4230 |
| Asns | -6276 |
| Atf2 | -8357 |
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
| 45 | |
|---|---|
| set | ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM |
| setSize | 12 |
| pANOVA | 0.0277 |
| s.dist | 0.367 |
| p.adjustANOVA | 0.292 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Elovl1 | 7986 |
| Acaa1a | 6080 |
| Acot8 | 5801 |
| Abcd1 | 5702 |
| Fads1 | 5189 |
| Hsd17b4 | 4959 |
| Fads2 | 4816 |
| Scp2 | 1613 |
| Elovl5 | 404 |
| Elovl2 | -903 |
| Acsl1 | -4238 |
| Acox1 | -5344 |
| GeneID | Gene Rank |
|---|---|
| Elovl1 | 7986 |
| Acaa1a | 6080 |
| Acot8 | 5801 |
| Abcd1 | 5702 |
| Fads1 | 5189 |
| Hsd17b4 | 4959 |
| Fads2 | 4816 |
| Scp2 | 1613 |
| Elovl5 | 404 |
| Elovl2 | -903 |
| Acsl1 | -4238 |
| Acox1 | -5344 |
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
| 163 | |
|---|---|
| set | COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES |
| setSize | 63 |
| pANOVA | 9.65e-07 |
| s.dist | 0.357 |
| p.adjustANOVA | 7.04e-05 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Bmp1 | 7814 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| P4ha2 | 7608 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Plod3 | 7307 |
| P3h3 | 7256 |
| Colgalt1 | 7126 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Serpinh1 | 6688 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Bmp1 | 7814 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| P4ha2 | 7608 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Plod3 | 7307 |
| P3h3 | 7256 |
| Colgalt1 | 7126 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Serpinh1 | 6688 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| P4ha3 | 5888 |
| Col4a2 | 5670 |
| P3h1 | 5214 |
| P4ha1 | 4858 |
| Col28a1 | 4763 |
| Pcolce | 4733 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Plod1 | 4559 |
| Col9a3 | 3789 |
| Ppib | 3226 |
| Col18a1 | 3050 |
| Col24a1 | 2997 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col17a1 | 2390 |
| Col6a5 | 2356 |
| Col20a1 | 1863 |
| Col4a3 | 1850 |
| Pcolce2 | 1603 |
| Col11a1 | 1221 |
| Tll2 | 1166 |
| Plod2 | 558 |
| Adamts14 | 546 |
| Col14a1 | -449 |
| Col19a1 | -590 |
| Col8a1 | -758 |
| Col4a1 | -844 |
| Col5a1 | -939 |
| P4hb | -1563 |
| Crtap | -3463 |
| Col23a1 | -3675 |
| Tll1 | -3733 |
| Colgalt2 | -3764 |
| Col9a1 | -4500 |
| Col6a6 | -5128 |
| Col25a1 | -5179 |
| Col22a1 | -5346 |
| Adamts2 | -5585 |
| P3h2 | -5829 |
| Adamts3 | -6206 |
| Col8a2 | -7555 |
NONSENSE MEDIATED DECAY NMD
| 629 | |
|---|---|
| set | NONSENSE MEDIATED DECAY NMD |
| setSize | 109 |
| pANOVA | 4.09e-10 |
| s.dist | 0.347 |
| p.adjustANOVA | 7.95e-08 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Upf3a | 7470 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Upf2 | 5920 |
| Rps27a | 5852 |
| Upf3b | 5809 |
| Eif4g1 | 5754 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Upf3a | 7470 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Upf2 | 5920 |
| Rps27a | 5852 |
| Upf3b | 5809 |
| Eif4g1 | 5754 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| Rpl6 | 5381 |
| Rbm8a | 5293 |
| Rps18 | 5259 |
| Rpl8 | 5182 |
| Casc3 | 5113 |
| Rps27l | 4781 |
| Eif4a3 | 4762 |
| Rpl35a | 4749 |
| Upf1 | 4646 |
| Rplp1 | 4497 |
| Rpl7a | 4489 |
| Rpl24 | 4485 |
| Rps25 | 4349 |
| Rps3a1 | 4211 |
| Rpl14 | 4027 |
| Rpl32 | 4021 |
| Rpl13 | 3983 |
| Rps17 | 3940 |
| Rps11 | 3934 |
| Rpl18a | 3929 |
| Uba52 | 3876 |
| Rpl12 | 3790 |
| Rpl10 | 3755 |
| Rps6 | 3747 |
| Fau | 3714 |
| Rpl30 | 3435 |
| Rps16 | 3425 |
| Rpl31 | 3267 |
| Magohb | 3263 |
| Rps14 | 3149 |
| Rps24 | 3077 |
| Rps15 | 3027 |
| Rpl21 | 3024 |
| Rps10 | 2979 |
| Rpl27a | 2892 |
| Rpl36al | 2751 |
| Rps7 | 2731 |
| Rpl19 | 2668 |
| Rpl3 | 2654 |
| Rpsa | 2614 |
| Rpl36 | 2443 |
| Rpl11 | 2320 |
| Rps5 | 2249 |
| Smg5 | 2199 |
| Rnps1 | 1880 |
| Rpl18 | 1869 |
| Ncbp2 | 1712 |
| Smg9 | 1705 |
| Rps27 | 1669 |
| Rpl9 | 1493 |
| Gspt2 | 1418 |
| Rpl5 | 1297 |
| Rps12 | 1217 |
| Rpl36a | 927 |
| Rpl10a | 895 |
| Rpl4 | 873 |
| Rps23 | 872 |
| Rpl22 | 732 |
| Ncbp1 | 630 |
| Rpl27 | 529 |
| Rpl13a | 406 |
| Ppp2r1a | 137 |
| Rps20 | -240 |
| Rplp0 | -309 |
| Rpl29 | -312 |
| Rpl34 | -373 |
| Rps3 | -775 |
| Pabpc1 | -1124 |
| Rpl7 | -1359 |
| Rps15a | -1947 |
| Magoh | -2121 |
| Smg8 | -2131 |
| Rpl39 | -2430 |
| Smg1 | -2440 |
| Ppp2ca | -2528 |
| Rpl17 | -2699 |
| Dcp1a | -2707 |
| Rpl15 | -3330 |
| Rpl22l1 | -3372 |
| Smg7 | -3557 |
| Smg6 | -4273 |
| Ppp2r2a | -4883 |
| Gspt1 | -5233 |
| Etf1 | -6408 |
| Pnrc2 | -7733 |
AGGREPHAGY
| 42 | |
|---|---|
| set | AGGREPHAGY |
| setSize | 35 |
| pANOVA | 0.00052 |
| s.dist | 0.339 |
| p.adjustANOVA | 0.0164 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hsf1 | 7863 |
| Prkn | 7558 |
| Tubb4a | 7514 |
| Vim | 7137 |
| Tubb3 | 7125 |
| Dynll2 | 6857 |
| Hdac6 | 6801 |
| Rps27a | 5852 |
| Tubb6 | 5562 |
| Cftr | 4729 |
| Vcp | 4709 |
| Park7 | 4550 |
| Dync1h1 | 4204 |
| Uba52 | 3876 |
| Tuba1b | 3388 |
| Ubc | 3089 |
| Tuba4a | 2983 |
| Pcnt | 2632 |
| Ubb | 2615 |
| Arl13b | 1722 |
| GeneID | Gene Rank |
|---|---|
| Hsf1 | 7863 |
| Prkn | 7558 |
| Tubb4a | 7514 |
| Vim | 7137 |
| Tubb3 | 7125 |
| Dynll2 | 6857 |
| Hdac6 | 6801 |
| Rps27a | 5852 |
| Tubb6 | 5562 |
| Cftr | 4729 |
| Vcp | 4709 |
| Park7 | 4550 |
| Dync1h1 | 4204 |
| Uba52 | 3876 |
| Tuba1b | 3388 |
| Ubc | 3089 |
| Tuba4a | 2983 |
| Pcnt | 2632 |
| Ubb | 2615 |
| Arl13b | 1722 |
| Tubb4b | 1266 |
| Dync1li1 | 1232 |
| Tubb2a | 982 |
| Tuba8 | 723 |
| Tubb2b | 597 |
| Dync1i1 | 565 |
| Ift88 | 268 |
| Ube2v1 | -76 |
| Tuba1c | -502 |
| Tuba1a | -1498 |
| Dynll1 | -2176 |
| Dync1i2 | -2459 |
| Dync1li2 | -3015 |
| Hsp90aa1 | -5314 |
| Ube2n | -6198 |
ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
| 73 | |
|---|---|
| set | ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES |
| setSize | 10 |
| pANOVA | 0.0637 |
| s.dist | -0.339 |
| p.adjustANOVA | 0.449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Angptl4 | -8438 |
| Lpl | -8375 |
| Creb3l3 | -7989 |
| Mbtps2 | -7343 |
| Pcsk5 | -5807 |
| Mbtps1 | -2771 |
| Lmf2 | 1837 |
| Lmf1 | 1892 |
| Furin | 2198 |
| Pcsk6 | 2268 |
| GeneID | Gene Rank |
|---|---|
| Angptl4 | -8438 |
| Lpl | -8375 |
| Creb3l3 | -7989 |
| Mbtps2 | -7343 |
| Pcsk5 | -5807 |
| Mbtps1 | -2771 |
| Lmf2 | 1837 |
| Lmf1 | 1892 |
| Furin | 2198 |
| Pcsk6 | 2268 |
COMPLEMENT CASCADE
| 168 | |
|---|---|
| set | COMPLEMENT CASCADE |
| setSize | 22 |
| pANOVA | 0.00603 |
| s.dist | 0.338 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| C2 | 7830 |
| Cfp | 7752 |
| C1qb | 6966 |
| Serping1 | 6861 |
| Masp2 | 5994 |
| C4b | 4905 |
| Clu | 4790 |
| C1qc | 4382 |
| Cd46 | 4241 |
| C8g | 3014 |
| C1qa | 3001 |
| Masp1 | 2826 |
| Cfh | 2570 |
| Cr1l | 1928 |
| Pros1 | 1027 |
| Cd81 | 869 |
| Cd55 | 766 |
| Gzmm | -547 |
| Cd59b | -1263 |
| C3ar1 | -2345 |
| GeneID | Gene Rank |
|---|---|
| C2 | 7830 |
| Cfp | 7752 |
| C1qb | 6966 |
| Serping1 | 6861 |
| Masp2 | 5994 |
| C4b | 4905 |
| Clu | 4790 |
| C1qc | 4382 |
| Cd46 | 4241 |
| C8g | 3014 |
| C1qa | 3001 |
| Masp1 | 2826 |
| Cfh | 2570 |
| Cr1l | 1928 |
| Pros1 | 1027 |
| Cd81 | 869 |
| Cd55 | 766 |
| Gzmm | -547 |
| Cd59b | -1263 |
| C3ar1 | -2345 |
| Vtn | -4402 |
| Cfb | -7716 |
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
| 884 | |
|---|---|
| set | ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS |
| setSize | 22 |
| pANOVA | 0.00603 |
| s.dist | 0.338 |
| p.adjustANOVA | 0.114 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pla2g6 | 7864 |
| Plpp4 | 7854 |
| Itpr3 | 7751 |
| Prkcd | 7667 |
| Plcg1 | 7468 |
| Pld1 | 6608 |
| Fcgr3 | 5696 |
| Itpr2 | 5108 |
| Fcgr1 | 5036 |
| Pld2 | 5001 |
| Plpp5 | 3070 |
| Plcg2 | 2455 |
| Pik3r2 | 1777 |
| Pik3ca | 1397 |
| Pld3 | 488 |
| Ahcyl1 | -536 |
| Pld4 | -741 |
| Pik3r1 | -2773 |
| Syk | -2933 |
| Pik3cb | -3280 |
| GeneID | Gene Rank |
|---|---|
| Pla2g6 | 7864 |
| Plpp4 | 7854 |
| Itpr3 | 7751 |
| Prkcd | 7667 |
| Plcg1 | 7468 |
| Pld1 | 6608 |
| Fcgr3 | 5696 |
| Itpr2 | 5108 |
| Fcgr1 | 5036 |
| Pld2 | 5001 |
| Plpp5 | 3070 |
| Plcg2 | 2455 |
| Pik3r2 | 1777 |
| Pik3ca | 1397 |
| Pld3 | 488 |
| Ahcyl1 | -536 |
| Pld4 | -741 |
| Pik3r1 | -2773 |
| Syk | -2933 |
| Pik3cb | -3280 |
| Itpr1 | -3732 |
| Prkce | -7798 |
MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS
| 528 | |
|---|---|
| set | MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS |
| setSize | 18 |
| pANOVA | 0.0132 |
| s.dist | -0.337 |
| p.adjustANOVA | 0.18 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ptpn4 | -8441 |
| Slc2a3 | -8428 |
| Oprk1 | -8305 |
| Met | -7793 |
| Creb1 | -7647 |
| Gria2 | -7584 |
| Grin2a | -7389 |
| Grin2b | -6592 |
| Mecp2 | -5261 |
| Hdac2 | -4517 |
| Trpc3 | -3236 |
| Gprin1 | -2848 |
| Sin3a | -516 |
| Oprm1 | -230 |
| Notch1 | 4059 |
| Ptpn1 | 4215 |
| Hdac1 | 4224 |
| Fkbp5 | 7973 |
| GeneID | Gene Rank |
|---|---|
| Ptpn4 | -8441 |
| Slc2a3 | -8428 |
| Oprk1 | -8305 |
| Met | -7793 |
| Creb1 | -7647 |
| Gria2 | -7584 |
| Grin2a | -7389 |
| Grin2b | -6592 |
| Mecp2 | -5261 |
| Hdac2 | -4517 |
| Trpc3 | -3236 |
| Gprin1 | -2848 |
| Sin3a | -516 |
| Oprm1 | -230 |
| Notch1 | 4059 |
| Ptpn1 | 4215 |
| Hdac1 | 4224 |
| Fkbp5 | 7973 |
CROSSLINKING OF COLLAGEN FIBRILS
| 189 | |
|---|---|
| set | CROSSLINKING OF COLLAGEN FIBRILS |
| setSize | 14 |
| pANOVA | 0.029 |
| s.dist | 0.337 |
| p.adjustANOVA | 0.296 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Bmp1 | 7814 |
| Col1a2 | 7492 |
| Loxl3 | 7065 |
| Col4a2 | 5670 |
| Pcolce | 4733 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col4a3 | 1850 |
| Loxl1 | 1235 |
| Tll2 | 1166 |
| Pxdn | 1009 |
| Col4a1 | -844 |
| Tll1 | -3733 |
| Lox | -4657 |
| GeneID | Gene Rank |
|---|---|
| Bmp1 | 7814 |
| Col1a2 | 7492 |
| Loxl3 | 7065 |
| Col4a2 | 5670 |
| Pcolce | 4733 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col4a3 | 1850 |
| Loxl1 | 1235 |
| Tll2 | 1166 |
| Pxdn | 1009 |
| Col4a1 | -844 |
| Tll1 | -3733 |
| Lox | -4657 |
SEMA4D IN SEMAPHORIN SIGNALING
| 908 | |
|---|---|
| set | SEMA4D IN SEMAPHORIN SIGNALING |
| setSize | 24 |
| pANOVA | 0.00468 |
| s.dist | 0.334 |
| p.adjustANOVA | 0.0976 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Plxnb1 | 6902 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rras | 6066 |
| Rhoc | 5770 |
| Rnd1 | 5407 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Arhgap35 | 2431 |
| Arhgef11 | 2057 |
| Erbb2 | 8 |
| Sema4d | -257 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Arhgef12 | -2059 |
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Plxnb1 | 6902 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rras | 6066 |
| Rhoc | 5770 |
| Rnd1 | 5407 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Arhgap35 | 2431 |
| Arhgef11 | 2057 |
| Erbb2 | 8 |
| Sema4d | -257 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Arhgef12 | -2059 |
| Rhoa | -3484 |
| Rhob | -5010 |
| Rac1 | -7094 |
| Met | -7793 |
ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING
| 300 | |
|---|---|
| set | ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING |
| setSize | 21 |
| pANOVA | 0.00855 |
| s.dist | -0.332 |
| p.adjustANOVA | 0.139 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mapk1 | -8630 |
| Creb1 | -7647 |
| Akt3 | -7429 |
| Btc | -6799 |
| Cdkn1b | -6707 |
| Uhmk1 | -6500 |
| Elk1 | -5299 |
| Foxo3 | -5228 |
| Xpo1 | -4807 |
| Ccnd1 | -4628 |
| Egf | -4464 |
| Tgfa | -3521 |
| Fos | -2716 |
| Srf | -1840 |
| Ptk2 | -1711 |
| Mapk3 | -652 |
| Egfr | -281 |
| Akt2 | 1546 |
| Hbegf | 1766 |
| Akt1 | 2472 |
| GeneID | Gene Rank |
|---|---|
| Mapk1 | -8630 |
| Creb1 | -7647 |
| Akt3 | -7429 |
| Btc | -6799 |
| Cdkn1b | -6707 |
| Uhmk1 | -6500 |
| Elk1 | -5299 |
| Foxo3 | -5228 |
| Xpo1 | -4807 |
| Ccnd1 | -4628 |
| Egf | -4464 |
| Tgfa | -3521 |
| Fos | -2716 |
| Srf | -1840 |
| Ptk2 | -1711 |
| Mapk3 | -652 |
| Egfr | -281 |
| Akt2 | 1546 |
| Hbegf | 1766 |
| Akt1 | 2472 |
| Bcl2 | 6063 |
SELENOAMINO ACID METABOLISM
| 905 | |
|---|---|
| set | SELENOAMINO ACID METABOLISM |
| setSize | 108 |
| pANOVA | 2.69e-09 |
| s.dist | 0.331 |
| p.adjustANOVA | 4.36e-07 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ahcy | 7694 |
| Rps28 | 7597 |
| Rps8 | 7450 |
| Gnmt | 7447 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Sars | 6629 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Aimp2 | 6285 |
| Rpl35 | 6264 |
| Mars1 | 6189 |
| Rpl23a | 6154 |
| Secisbp2 | 6007 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| GeneID | Gene Rank |
|---|---|
| Ahcy | 7694 |
| Rps28 | 7597 |
| Rps8 | 7450 |
| Gnmt | 7447 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Sars | 6629 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Aimp2 | 6285 |
| Rpl35 | 6264 |
| Mars1 | 6189 |
| Rpl23a | 6154 |
| Secisbp2 | 6007 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| Rpl6 | 5381 |
| Rps18 | 5259 |
| Rpl8 | 5182 |
| Rps27l | 4781 |
| Rpl35a | 4749 |
| Rplp1 | 4497 |
| Rpl7a | 4489 |
| Rpl24 | 4485 |
| Rps25 | 4349 |
| Rps3a1 | 4211 |
| Rpl14 | 4027 |
| Rpl32 | 4021 |
| Rpl13 | 3983 |
| Rps17 | 3940 |
| Rps11 | 3934 |
| Rpl18a | 3929 |
| Uba52 | 3876 |
| Rpl12 | 3790 |
| Rpl10 | 3755 |
| Rps6 | 3747 |
| Fau | 3714 |
| Rpl30 | 3435 |
| Rps16 | 3425 |
| Iars | 3409 |
| Rpl31 | 3267 |
| Rps14 | 3149 |
| Rps24 | 3077 |
| Rps15 | 3027 |
| Rpl21 | 3024 |
| Rps10 | 2979 |
| Rpl27a | 2892 |
| Rpl36al | 2751 |
| Rps7 | 2731 |
| Cbs | 2675 |
| Rpl19 | 2668 |
| Rpl3 | 2654 |
| Rpsa | 2614 |
| Eprs | 2605 |
| Rpl36 | 2443 |
| Rpl11 | 2320 |
| Rps5 | 2249 |
| Rpl18 | 1869 |
| Rps27 | 1669 |
| Rpl9 | 1493 |
| Aimp1 | 1374 |
| Rpl5 | 1297 |
| Rps12 | 1217 |
| Papss1 | 1045 |
| Rpl36a | 927 |
| Scly | 914 |
| Rpl10a | 895 |
| Rpl4 | 873 |
| Rps23 | 872 |
| Rpl22 | 732 |
| Rpl27 | 529 |
| Rpl13a | 406 |
| Eefsec | 40 |
| Rps20 | -240 |
| Kars | -285 |
| Rplp0 | -309 |
| Rpl29 | -312 |
| Rpl34 | -373 |
| Rps3 | -775 |
| Eef1e1 | -1262 |
| Cth | -1320 |
| Rpl7 | -1359 |
| Lars | -1628 |
| Rps15a | -1947 |
| Rpl39 | -2430 |
| Rpl17 | -2699 |
| Rars | -3016 |
| Qars | -3269 |
| Rpl15 | -3330 |
| Gsr | -3354 |
| Rpl22l1 | -3372 |
| Pstk | -3567 |
| Txnrd1 | -3581 |
| Papss2 | -5732 |
| Sepsecs | -6611 |
| Dars | -7284 |
| Hnmt | -7349 |
| Sephs2 | -7623 |
P75NTR SIGNALS VIA NF KB
| 675 | |
|---|---|
| set | P75NTR SIGNALS VIA NF KB |
| setSize | 16 |
| pANOVA | 0.025 |
| s.dist | 0.324 |
| p.adjustANOVA | 0.273 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Myd88 | 6716 |
| Ikbkb | 6593 |
| Nfkb1 | 6575 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Nfkbia | 2118 |
| Sqstm1 | 727 |
| Rela | 29 |
| Ripk2 | -3192 |
| Traf6 | -3825 |
| Prkci | -8596 |
| GeneID | Gene Rank |
|---|---|
| Myd88 | 6716 |
| Ikbkb | 6593 |
| Nfkb1 | 6575 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Nfkbia | 2118 |
| Sqstm1 | 727 |
| Rela | 29 |
| Ripk2 | -3192 |
| Traf6 | -3825 |
| Prkci | -8596 |
ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS
| 6 | |
|---|---|
| set | ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS |
| setSize | 17 |
| pANOVA | 0.0225 |
| s.dist | -0.32 |
| p.adjustANOVA | 0.257 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Cdkn1a | -8508 |
| E2f3 | -6816 |
| Cdkn1b | -6707 |
| Rb1 | -6356 |
| Ccne2 | -5713 |
| E2f2 | -5139 |
| E2f1 | -4656 |
| Ccnd2 | -4633 |
| Ccnd1 | -4628 |
| Cdkn1c | -4601 |
| Tfdp2 | -3110 |
| Cdk6 | -2299 |
| Tfdp1 | -2272 |
| Cdk4 | 2011 |
| Ccne1 | 2945 |
| Cdk2 | 2990 |
| Ccnd3 | 4933 |
| GeneID | Gene Rank |
|---|---|
| Cdkn1a | -8508 |
| E2f3 | -6816 |
| Cdkn1b | -6707 |
| Rb1 | -6356 |
| Ccne2 | -5713 |
| E2f2 | -5139 |
| E2f1 | -4656 |
| Ccnd2 | -4633 |
| Ccnd1 | -4628 |
| Cdkn1c | -4601 |
| Tfdp2 | -3110 |
| Cdk6 | -2299 |
| Tfdp1 | -2272 |
| Cdk4 | 2011 |
| Ccne1 | 2945 |
| Cdk2 | 2990 |
| Ccnd3 | 4933 |
CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND
| 117 | |
|---|---|
| set | CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND |
| setSize | 10 |
| pANOVA | 0.0806 |
| s.dist | -0.319 |
| p.adjustANOVA | 0.48 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Casp3 | -7553 |
| Dcc | -7423 |
| Unc5b | -6259 |
| Appl1 | -5628 |
| Dapk2 | -4725 |
| Casp9 | -4449 |
| Maged1 | -3228 |
| Unc5a | -2134 |
| Dapk1 | 4834 |
| Dapk3 | 5681 |
| GeneID | Gene Rank |
|---|---|
| Casp3 | -7553 |
| Dcc | -7423 |
| Unc5b | -6259 |
| Appl1 | -5628 |
| Dapk2 | -4725 |
| Casp9 | -4449 |
| Maged1 | -3228 |
| Unc5a | -2134 |
| Dapk1 | 4834 |
| Dapk3 | 5681 |
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
| 74 | |
|---|---|
| set | ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES |
| setSize | 51 |
| pANOVA | 8.18e-05 |
| s.dist | 0.319 |
| p.adjustANOVA | 0.00354 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Bmp1 | 7814 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Loxl3 | 7065 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Plec | 6231 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Col4a2 | 5670 |
| Ctsl | 4853 |
| Pcolce | 4733 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| GeneID | Gene Rank |
|---|---|
| Bmp1 | 7814 |
| Col9a2 | 7757 |
| Col27a1 | 7737 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Loxl3 | 7065 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Plec | 6231 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Col4a2 | 5670 |
| Ctsl | 4853 |
| Pcolce | 4733 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Col9a3 | 3789 |
| Col18a1 | 3050 |
| Col24a1 | 2997 |
| Cd151 | 2679 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col17a1 | 2390 |
| Col6a5 | 2356 |
| Mmp9 | 1954 |
| Col4a3 | 1850 |
| Dst | 1522 |
| Lamb3 | 1434 |
| Loxl1 | 1235 |
| Col11a1 | 1221 |
| Tll2 | 1166 |
| Pxdn | 1009 |
| Col14a1 | -449 |
| Itgb4 | -468 |
| Col8a1 | -758 |
| Col4a1 | -844 |
| Itga6 | -930 |
| Col5a1 | -939 |
| Ctsb | -1721 |
| Ctss | -1913 |
| Tll1 | -3733 |
| Col9a1 | -4500 |
| Lox | -4657 |
| Col6a6 | -5128 |
| Lamc2 | -5811 |
| Col8a2 | -7555 |
| Lama3 | -8651 |
SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
| 1004 | |
|---|---|
| set | SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE |
| setSize | 106 |
| pANOVA | 1.55e-08 |
| s.dist | 0.318 |
| p.adjustANOVA | 1.81e-06 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| GeneID | Gene Rank |
|---|---|
| Rps28 | 7597 |
| Rps8 | 7450 |
| Rpl26 | 7359 |
| Rpl28 | 7124 |
| Rpl38 | 6634 |
| Rplp2 | 6619 |
| Rps29 | 6609 |
| Rpl35 | 6264 |
| Rpl23a | 6154 |
| Rps13 | 5967 |
| Rps27a | 5852 |
| Rps21 | 5714 |
| Rps2 | 5693 |
| Rpl23 | 5633 |
| Rps9 | 5593 |
| Rpl37a | 5545 |
| Rps4x | 5533 |
| Rps26 | 5531 |
| Rpl37 | 5530 |
| Rps19 | 5400 |
| Rpl6 | 5381 |
| Rps18 | 5259 |
| Rpl8 | 5182 |
| Srp72 | 5118 |
| Srpr | 4813 |
| Rps27l | 4781 |
| Rpl35a | 4749 |
| Rplp1 | 4497 |
| Rpl7a | 4489 |
| Rpl24 | 4485 |
| Rps25 | 4349 |
| Rps3a1 | 4211 |
| Sec11c | 4176 |
| Rpl14 | 4027 |
| Rpl32 | 4021 |
| Rpl13 | 3983 |
| Rps17 | 3940 |
| Rps11 | 3934 |
| Rpl18a | 3929 |
| Uba52 | 3876 |
| Srprb | 3806 |
| Rpl12 | 3790 |
| Rpl10 | 3755 |
| Rps6 | 3747 |
| Fau | 3714 |
| Rpl30 | 3435 |
| Rps16 | 3425 |
| Srp19 | 3357 |
| Rpl31 | 3267 |
| Sec11a | 3241 |
| Rps14 | 3149 |
| Rps24 | 3077 |
| Rps15 | 3027 |
| Rpl21 | 3024 |
| Rps10 | 2979 |
| Rpl27a | 2892 |
| Rpl36al | 2751 |
| Rps7 | 2731 |
| Rpl19 | 2668 |
| Rpl3 | 2654 |
| Rpsa | 2614 |
| Rpl36 | 2443 |
| Rpl11 | 2320 |
| Rps5 | 2249 |
| Rpl18 | 1869 |
| Rpn2 | 1760 |
| Sec61a2 | 1735 |
| Rps27 | 1669 |
| Rpl9 | 1493 |
| Rpl5 | 1297 |
| Rps12 | 1217 |
| Sec61b | 1077 |
| Srp68 | 978 |
| Srp14 | 947 |
| Rpl36a | 927 |
| Rpl10a | 895 |
| Rpl4 | 873 |
| Rps23 | 872 |
| Spcs1 | 764 |
| Rpl22 | 732 |
| Rpl27 | 529 |
| Rpl13a | 406 |
| Ssr4 | -188 |
| Rps20 | -240 |
| Rplp0 | -309 |
| Rpl29 | -312 |
| Rpl34 | -373 |
| Rps3 | -775 |
| Spcs2 | -1146 |
| Rpl7 | -1359 |
| Ddost | -1477 |
| Rps15a | -1947 |
| Sec61a1 | -2415 |
| Rpl39 | -2430 |
| Ssr2 | -2654 |
| Rpl17 | -2699 |
| Srp9 | -3121 |
| Rpl15 | -3330 |
| Rpl22l1 | -3372 |
| Rpn1 | -4199 |
| Sec61g | -4276 |
| Ssr1 | -5676 |
| Srp54a | -5701 |
| Ssr3 | -5770 |
| Spcs3 | -7102 |
| Tram1 | -8162 |
FERTILIZATION
| 317 | |
|---|---|
| set | FERTILIZATION |
| setSize | 12 |
| pANOVA | 0.0567 |
| s.dist | 0.318 |
| p.adjustANOVA | 0.434 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Izumo4 | 7532 |
| Catsperg1 | 6963 |
| Ovgp1 | 6808 |
| Catsperd | 6036 |
| Adam21 | 4738 |
| Catsperg2 | 4262 |
| Catsper2 | 2372 |
| Kcnu1 | 1703 |
| Acr | 619 |
| B4galt1 | -3841 |
| Cd9 | -4535 |
| Hvcn1 | -5555 |
| GeneID | Gene Rank |
|---|---|
| Izumo4 | 7532 |
| Catsperg1 | 6963 |
| Ovgp1 | 6808 |
| Catsperd | 6036 |
| Adam21 | 4738 |
| Catsperg2 | 4262 |
| Catsper2 | 2372 |
| Kcnu1 | 1703 |
| Acr | 619 |
| B4galt1 | -3841 |
| Cd9 | -4535 |
| Hvcn1 | -5555 |
POST CHAPERONIN TUBULIN FOLDING PATHWAY
| 722 | |
|---|---|
| set | POST CHAPERONIN TUBULIN FOLDING PATHWAY |
| setSize | 17 |
| pANOVA | 0.0236 |
| s.dist | 0.317 |
| p.adjustANOVA | 0.262 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 7514 |
| Tubb3 | 7125 |
| Tubb6 | 5562 |
| Arl2 | 4776 |
| Tbcb | 4619 |
| Tbca | 4002 |
| Tuba1b | 3388 |
| Tuba4a | 2983 |
| Tbcd | 2217 |
| Tubb4b | 1266 |
| Tubb2a | 982 |
| Tuba8 | 723 |
| Tubb2b | 597 |
| Tbcc | -144 |
| Tuba1c | -502 |
| Tuba1a | -1498 |
| Tbce | -5313 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 7514 |
| Tubb3 | 7125 |
| Tubb6 | 5562 |
| Arl2 | 4776 |
| Tbcb | 4619 |
| Tbca | 4002 |
| Tuba1b | 3388 |
| Tuba4a | 2983 |
| Tbcd | 2217 |
| Tubb4b | 1266 |
| Tubb2a | 982 |
| Tuba8 | 723 |
| Tubb2b | 597 |
| Tbcc | -144 |
| Tuba1c | -502 |
| Tuba1a | -1498 |
| Tbce | -5313 |
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
| 1129 | |
|---|---|
| set | TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE |
| setSize | 13 |
| pANOVA | 0.0478 |
| s.dist | 0.317 |
| p.adjustANOVA | 0.387 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 7514 |
| Tubb3 | 7125 |
| Tubb6 | 5562 |
| Tuba1b | 3388 |
| Tuba4a | 2983 |
| Gjb2 | 1872 |
| Tubb4b | 1266 |
| Tubb2a | 982 |
| Tuba8 | 723 |
| Tubb2b | 597 |
| Tuba1c | -502 |
| Gja1 | -720 |
| Tuba1a | -1498 |
| GeneID | Gene Rank |
|---|---|
| Tubb4a | 7514 |
| Tubb3 | 7125 |
| Tubb6 | 5562 |
| Tuba1b | 3388 |
| Tuba4a | 2983 |
| Gjb2 | 1872 |
| Tubb4b | 1266 |
| Tubb2a | 982 |
| Tuba8 | 723 |
| Tubb2b | 597 |
| Tuba1c | -502 |
| Gja1 | -720 |
| Tuba1a | -1498 |
CD28 DEPENDENT VAV1 PATHWAY
| 123 | |
|---|---|
| set | CD28 DEPENDENT VAV1 PATHWAY |
| setSize | 11 |
| pANOVA | 0.0687 |
| s.dist | -0.317 |
| p.adjustANOVA | 0.449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pak1 | -7266 |
| Rac1 | -7094 |
| Cd86 | -6957 |
| Cdc42 | -6790 |
| Lck | -5243 |
| Fyn | -4003 |
| Pak3 | -3689 |
| Grb2 | -3233 |
| Pak2 | -2269 |
| Cd80 | 5006 |
| Vav1 | 7763 |
| GeneID | Gene Rank |
|---|---|
| Pak1 | -7266 |
| Rac1 | -7094 |
| Cd86 | -6957 |
| Cdc42 | -6790 |
| Lck | -5243 |
| Fyn | -4003 |
| Pak3 | -3689 |
| Grb2 | -3233 |
| Pak2 | -2269 |
| Cd80 | 5006 |
| Vav1 | 7763 |
NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
| 634 | |
|---|---|
| set | NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION |
| setSize | 11 |
| pANOVA | 0.0708 |
| s.dist | -0.315 |
| p.adjustANOVA | 0.449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hes1 | -8398 |
| Creb1 | -7647 |
| Rbpj | -6451 |
| Fcer2a | -6103 |
| Mamld1 | -6045 |
| Maml1 | -5814 |
| Maml2 | -3706 |
| Ep300 | -801 |
| Notch2 | 1342 |
| Maml3 | 3509 |
| Hes5 | 6550 |
| GeneID | Gene Rank |
|---|---|
| Hes1 | -8398 |
| Creb1 | -7647 |
| Rbpj | -6451 |
| Fcer2a | -6103 |
| Mamld1 | -6045 |
| Maml1 | -5814 |
| Maml2 | -3706 |
| Ep300 | -801 |
| Notch2 | 1342 |
| Maml3 | 3509 |
| Hes5 | 6550 |
INSULIN PROCESSING
| 449 | |
|---|---|
| set | INSULIN PROCESSING |
| setSize | 24 |
| pANOVA | 0.00789 |
| s.dist | -0.313 |
| p.adjustANOVA | 0.132 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Exoc5 | -8628 |
| Exoc6 | -8582 |
| Slc30a5 | -8069 |
| Pcsk2 | -7692 |
| Exoc2 | -6922 |
| Slc30a7 | -6645 |
| Ero1a | -6454 |
| Myrip | -5647 |
| Kif5c | -5367 |
| Cpe | -5080 |
| Myo5a | -5057 |
| Kif5b | -3438 |
| Exoc1 | -3319 |
| Ero1b | -2868 |
| Rab27a | -2778 |
| Kif5a | -2298 |
| Pcsk1 | -1677 |
| Slc30a6 | -1209 |
| Vamp2 | -235 |
| Exoc3 | 451 |
| GeneID | Gene Rank |
|---|---|
| Exoc5 | -8628 |
| Exoc6 | -8582 |
| Slc30a5 | -8069 |
| Pcsk2 | -7692 |
| Exoc2 | -6922 |
| Slc30a7 | -6645 |
| Ero1a | -6454 |
| Myrip | -5647 |
| Kif5c | -5367 |
| Cpe | -5080 |
| Myo5a | -5057 |
| Kif5b | -3438 |
| Exoc1 | -3319 |
| Ero1b | -2868 |
| Rab27a | -2778 |
| Kif5a | -2298 |
| Pcsk1 | -1677 |
| Slc30a6 | -1209 |
| Vamp2 | -235 |
| Exoc3 | 451 |
| Stx1a | 1991 |
| Exoc8 | 4506 |
| Exoc4 | 4818 |
| Exoc7 | 7290 |
RHO GTPASES ACTIVATE ROCKS
| 848 | |
|---|---|
| set | RHO GTPASES ACTIVATE ROCKS |
| setSize | 19 |
| pANOVA | 0.0184 |
| s.dist | 0.313 |
| p.adjustANOVA | 0.227 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rhoc | 5770 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Ppp1r12a | 1973 |
| Ppp1r12b | 1690 |
| Cfl1 | 3 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Rhoa | -3484 |
| Rhob | -5010 |
| Ppp1cb | -6009 |
| Pak1 | -7266 |
| GeneID | Gene Rank |
|---|---|
| Myl9 | 7852 |
| Myh11 | 7708 |
| Myh14 | 7493 |
| Limk2 | 7421 |
| Limk1 | 6628 |
| Myh9 | 6341 |
| Rhoc | 5770 |
| Myl6 | 4895 |
| Myl12b | 4330 |
| Myh10 | 3504 |
| Ppp1r12a | 1973 |
| Ppp1r12b | 1690 |
| Cfl1 | 3 |
| Rock2 | -657 |
| Rock1 | -1112 |
| Rhoa | -3484 |
| Rhob | -5010 |
| Ppp1cb | -6009 |
| Pak1 | -7266 |
PEXOPHAGY
| 687 | |
|---|---|
| set | PEXOPHAGY |
| setSize | 11 |
| pANOVA | 0.0755 |
| s.dist | 0.31 |
| p.adjustANOVA | 0.468 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Epas1 | 7120 |
| Pex5 | 5945 |
| Rps27a | 5852 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Map1lc3b | 2184 |
| Nbr1 | 1545 |
| Sqstm1 | 727 |
| Usp30 | -445 |
| Atm | -8415 |
| GeneID | Gene Rank |
|---|---|
| Epas1 | 7120 |
| Pex5 | 5945 |
| Rps27a | 5852 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Map1lc3b | 2184 |
| Nbr1 | 1545 |
| Sqstm1 | 727 |
| Usp30 | -445 |
| Atm | -8415 |
TIGHT JUNCTION INTERACTIONS
| 1071 | |
|---|---|
| set | TIGHT JUNCTION INTERACTIONS |
| setSize | 18 |
| pANOVA | 0.0231 |
| s.dist | -0.309 |
| p.adjustANOVA | 0.26 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Crb3 | -8748 |
| Prkci | -8596 |
| Cldn3 | -8209 |
| Cldn2 | -7403 |
| Cldn1 | -6903 |
| Pard6b | -5977 |
| Pard6g | -5913 |
| Pard6a | -5895 |
| Cldn5 | -4581 |
| Cldn10 | -3261 |
| Pals1 | -2577 |
| Cldn23 | -1580 |
| Cldn12 | -1182 |
| F11r | 462 |
| Cldn11 | 1022 |
| Pard3 | 3801 |
| Cldn14 | 5169 |
| Patj | 6287 |
| GeneID | Gene Rank |
|---|---|
| Crb3 | -8748 |
| Prkci | -8596 |
| Cldn3 | -8209 |
| Cldn2 | -7403 |
| Cldn1 | -6903 |
| Pard6b | -5977 |
| Pard6g | -5913 |
| Pard6a | -5895 |
| Cldn5 | -4581 |
| Cldn10 | -3261 |
| Pals1 | -2577 |
| Cldn23 | -1580 |
| Cldn12 | -1182 |
| F11r | 462 |
| Cldn11 | 1022 |
| Pard3 | 3801 |
| Cldn14 | 5169 |
| Patj | 6287 |
E2F MEDIATED REGULATION OF DNA REPLICATION
| 270 | |
|---|---|
| set | E2F MEDIATED REGULATION OF DNA REPLICATION |
| setSize | 19 |
| pANOVA | 0.0205 |
| s.dist | -0.307 |
| p.adjustANOVA | 0.236 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Orc3 | -8141 |
| Ppp2cb | -8046 |
| Orc5 | -7741 |
| Orc4 | -6544 |
| Rb1 | -6356 |
| Orc6 | -5379 |
| E2f1 | -4656 |
| Tfdp2 | -3110 |
| Mcm8 | -2883 |
| Prim1 | -2873 |
| Ppp2ca | -2528 |
| Tfdp1 | -2272 |
| Orc2 | -1709 |
| Ppp2r1b | -941 |
| Prim2 | -243 |
| Ppp2r1a | 137 |
| Pola2 | 980 |
| Pola1 | 1144 |
| Ppp2r3d | 4405 |
| GeneID | Gene Rank |
|---|---|
| Orc3 | -8141 |
| Ppp2cb | -8046 |
| Orc5 | -7741 |
| Orc4 | -6544 |
| Rb1 | -6356 |
| Orc6 | -5379 |
| E2f1 | -4656 |
| Tfdp2 | -3110 |
| Mcm8 | -2883 |
| Prim1 | -2873 |
| Ppp2ca | -2528 |
| Tfdp1 | -2272 |
| Orc2 | -1709 |
| Ppp2r1b | -941 |
| Prim2 | -243 |
| Ppp2r1a | 137 |
| Pola2 | 980 |
| Pola1 | 1144 |
| Ppp2r3d | 4405 |
P75NTR RECRUITS SIGNALLING COMPLEXES
| 673 | |
|---|---|
| set | P75NTR RECRUITS SIGNALLING COMPLEXES |
| setSize | 13 |
| pANOVA | 0.0553 |
| s.dist | 0.307 |
| p.adjustANOVA | 0.427 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Myd88 | 6716 |
| Ikbkb | 6593 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Sqstm1 | 727 |
| Ripk2 | -3192 |
| Traf6 | -3825 |
| Prkci | -8596 |
| GeneID | Gene Rank |
|---|---|
| Myd88 | 6716 |
| Ikbkb | 6593 |
| Irak1 | 6335 |
| Rps27a | 5852 |
| Ngfr | 5541 |
| Uba52 | 3876 |
| Ubc | 3089 |
| Ubb | 2615 |
| Ngf | 2468 |
| Sqstm1 | 727 |
| Ripk2 | -3192 |
| Traf6 | -3825 |
| Prkci | -8596 |
RNA POLYMERASE II TRANSCRIPTION TERMINATION
| 874 | |
|---|---|
| set | RNA POLYMERASE II TRANSCRIPTION TERMINATION |
| setSize | 65 |
| pANOVA | 1.88e-05 |
| s.dist | 0.307 |
| p.adjustANOVA | 0.000998 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Srsf4 | 7950 |
| Zc3h11a | 7655 |
| Snrpf | 7556 |
| Srsf9 | 7513 |
| Cpsf1 | 7480 |
| Dhx38 | 7462 |
| Pabpn1 | 7401 |
| Srsf2 | 7200 |
| Ddx39a | 7174 |
| U2af1 | 7002 |
| Alyref | 6744 |
| Srsf6 | 6718 |
| Cpsf4 | 6689 |
| Srrm1 | 6369 |
| Cpsf7 | 6324 |
| Sympk | 5955 |
| U2af1l4 | 5879 |
| Ddx39b | 5833 |
| Upf3b | 5809 |
| Snrpb | 5626 |
| GeneID | Gene Rank |
|---|---|
| Srsf4 | 7950 |
| Zc3h11a | 7655 |
| Snrpf | 7556 |
| Srsf9 | 7513 |
| Cpsf1 | 7480 |
| Dhx38 | 7462 |
| Pabpn1 | 7401 |
| Srsf2 | 7200 |
| Ddx39a | 7174 |
| U2af1 | 7002 |
| Alyref | 6744 |
| Srsf6 | 6718 |
| Cpsf4 | 6689 |
| Srrm1 | 6369 |
| Cpsf7 | 6324 |
| Sympk | 5955 |
| U2af1l4 | 5879 |
| Ddx39b | 5833 |
| Upf3b | 5809 |
| Snrpb | 5626 |
| U2af2 | 5490 |
| Cstf3 | 5338 |
| Srsf1 | 5312 |
| Srsf11 | 5304 |
| Rbm8a | 5293 |
| Sarnp | 5125 |
| Casc3 | 5113 |
| Thoc6 | 4876 |
| Eif4a3 | 4762 |
| Thoc5 | 4461 |
| Zfp473 | 4029 |
| Cstf2 | 3654 |
| Cpsf3 | 3473 |
| Magohb | 3263 |
| Slu7 | 3125 |
| Srsf5 | 2852 |
| Poldip3 | 2055 |
| Rnps1 | 1880 |
| Ncbp2 | 1712 |
| Snrpg | 1226 |
| Cstf1 | 1127 |
| Thoc1 | 1115 |
| Fip1l1 | 1013 |
| Ncbp1 | 630 |
| Papola | 592 |
| Wdr33 | 242 |
| Snrpe | 67 |
| Chtop | -246 |
| Thoc7 | -394 |
| Lsm10 | -1318 |
| Srsf7 | -1588 |
| Magoh | -2121 |
| Nudt21 | -2125 |
| Cdc40 | -2471 |
| Pcf11 | -2877 |
| Srsf3 | -3336 |
| Thoc2 | -3961 |
| Lsm11 | -5020 |
| Snrpd3 | -6248 |
| Cstf2t | -7252 |
| Clp1 | -7568 |
| Thoc3 | -7896 |
| Slbp | -7908 |
| Cpsf2 | -8203 |
| Fyttd1 | -8539 |
REDUCTION OF CYTOSOLIC CA LEVELS
| 781 | |
|---|---|
| set | REDUCTION OF CYTOSOLIC CA LEVELS |
| setSize | 11 |
| pANOVA | 0.0804 |
| s.dist | -0.304 |
| p.adjustANOVA | 0.48 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Slc8a1 | -8586 |
| Calm1 | -6803 |
| Atp2b4 | -6663 |
| Atp2a2 | -5583 |
| Atp2b1 | -4619 |
| Sri | -3789 |
| Atp2a3 | -1039 |
| Slc8a2 | -990 |
| Atp2b3 | -261 |
| Atp2b2 | 400 |
| Slc8a3 | 5314 |
| GeneID | Gene Rank |
|---|---|
| Slc8a1 | -8586 |
| Calm1 | -6803 |
| Atp2b4 | -6663 |
| Atp2a2 | -5583 |
| Atp2b1 | -4619 |
| Sri | -3789 |
| Atp2a3 | -1039 |
| Slc8a2 | -990 |
| Atp2b3 | -261 |
| Atp2b2 | 400 |
| Slc8a3 | 5314 |
COLLAGEN DEGRADATION
| 165 | |
|---|---|
| set | COLLAGEN DEGRADATION |
| setSize | 51 |
| pANOVA | 0.000187 |
| s.dist | 0.303 |
| p.adjustANOVA | 0.00726 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Mmp19 | 5794 |
| Col4a2 | 5670 |
| Ctsl | 4853 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Mmp15 | 4535 |
| GeneID | Gene Rank |
|---|---|
| Col13a1 | 7899 |
| Col26a1 | 7772 |
| Col9a2 | 7757 |
| Col11a2 | 7685 |
| Col12a1 | 7671 |
| Col1a2 | 7492 |
| Col16a1 | 7367 |
| Col2a1 | 7012 |
| Col5a2 | 6994 |
| Col7a1 | 6814 |
| Col5a3 | 6711 |
| Col6a2 | 6291 |
| Col3a1 | 5984 |
| Col6a1 | 5959 |
| Mmp19 | 5794 |
| Col4a2 | 5670 |
| Ctsl | 4853 |
| Col6a3 | 4621 |
| Col15a1 | 4606 |
| Mmp15 | 4535 |
| Ctsk | 4049 |
| Col9a3 | 3789 |
| Adam9 | 3081 |
| Col18a1 | 3050 |
| Tmprss6 | 2868 |
| Col1a1 | 2599 |
| Col4a5 | 2486 |
| Col17a1 | 2390 |
| Col6a5 | 2356 |
| Furin | 2198 |
| Mmp9 | 1954 |
| Col4a3 | 1850 |
| Col11a1 | 1221 |
| Phykpl | 93 |
| Col14a1 | -449 |
| Col19a1 | -590 |
| Ctsd | -733 |
| Col8a1 | -758 |
| Adam17 | -843 |
| Col4a1 | -844 |
| Col5a1 | -939 |
| Ctsb | -1721 |
| Mmp14 | -3447 |
| Col23a1 | -3675 |
| Col9a1 | -4500 |
| Col6a6 | -5128 |
| Col25a1 | -5179 |
| Mmp2 | -5447 |
| Adam10 | -5747 |
| Mmp11 | -7537 |
| Col8a2 | -7555 |
LYSOSPHINGOLIPID AND LPA RECEPTORS
| 519 | |
|---|---|
| set | LYSOSPHINGOLIPID AND LPA RECEPTORS |
| setSize | 12 |
| pANOVA | 0.0702 |
| s.dist | -0.302 |
| p.adjustANOVA | 0.449 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Plppr5 | -8371 |
| Plppr4 | -7718 |
| S1pr1 | -6232 |
| Plppr1 | -6119 |
| S1pr2 | -5470 |
| Lpar1 | -3230 |
| Lpar2 | -2736 |
| Plppr2 | -2017 |
| S1pr5 | -1545 |
| S1pr4 | -703 |
| S1pr3 | 2254 |
| Plppr3 | 6567 |
| GeneID | Gene Rank |
|---|---|
| Plppr5 | -8371 |
| Plppr4 | -7718 |
| S1pr1 | -6232 |
| Plppr1 | -6119 |
| S1pr2 | -5470 |
| Lpar1 | -3230 |
| Lpar2 | -2736 |
| Plppr2 | -2017 |
| S1pr5 | -1545 |
| S1pr4 | -703 |
| S1pr3 | 2254 |
| Plppr3 | 6567 |
CGMP EFFECTS
| 141 | |
|---|---|
| set | CGMP EFFECTS |
| setSize | 15 |
| pANOVA | 0.0432 |
| s.dist | -0.301 |
| p.adjustANOVA | 0.371 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pde1a | -8709 |
| Kcnma1 | -7641 |
| Prkg1 | -6664 |
| Kcnmb1 | -5795 |
| Pde11a | -4241 |
| Itpr1 | -3732 |
| Pde2a | -3715 |
| Pde9a | -2935 |
| Kcnmb4 | -2881 |
| Pde10a | -2223 |
| Pde5a | -1891 |
| Pde1b | 313 |
| Kcnmb2 | 1566 |
| Irag1 | 2032 |
| Prkg2 | 2417 |
| GeneID | Gene Rank |
|---|---|
| Pde1a | -8709 |
| Kcnma1 | -7641 |
| Prkg1 | -6664 |
| Kcnmb1 | -5795 |
| Pde11a | -4241 |
| Itpr1 | -3732 |
| Pde2a | -3715 |
| Pde9a | -2935 |
| Kcnmb4 | -2881 |
| Pde10a | -2223 |
| Pde5a | -1891 |
| Pde1b | 313 |
| Kcnmb2 | 1566 |
| Irag1 | 2032 |
| Prkg2 | 2417 |
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
| 1029 | |
|---|---|
| set | SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL |
| setSize | 13 |
| pANOVA | 0.0602 |
| s.dist | 0.301 |
| p.adjustANOVA | 0.447 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ptgis | 7770 |
| Slc27a2 | 6336 |
| Rxra | 5870 |
| Cyp27a1 | 5848 |
| Acot8 | 5801 |
| Hsd17b4 | 4959 |
| Hsd3b7 | 4665 |
| Scp2 | 1613 |
| Slc27a5 | 716 |
| Cyp7b1 | -698 |
| Ncoa2 | -4279 |
| Ncoa1 | -5337 |
| Amacr | -5715 |
| GeneID | Gene Rank |
|---|---|
| Ptgis | 7770 |
| Slc27a2 | 6336 |
| Rxra | 5870 |
| Cyp27a1 | 5848 |
| Acot8 | 5801 |
| Hsd17b4 | 4959 |
| Hsd3b7 | 4665 |
| Scp2 | 1613 |
| Slc27a5 | 716 |
| Cyp7b1 | -698 |
| Ncoa2 | -4279 |
| Ncoa1 | -5337 |
| Amacr | -5715 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.1.3 (2022-03-10)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 20.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.9.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.9.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.2.4 GGally_2.1.2
## [3] gtools_3.9.2 echarts4r_0.4.3
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7 kableExtra_1.3.4
## [9] topconfects_1.8.0 limma_3.48.3
## [11] eulerr_6.1.1 mitch_1.4.1
## [13] MASS_7.3-55 fgsea_1.18.0
## [15] gplots_3.1.1 DESeq2_1.32.0
## [17] SummarizedExperiment_1.22.0 Biobase_2.52.0
## [19] MatrixGenerics_1.4.3 matrixStats_0.61.0
## [21] GenomicRanges_1.44.0 GenomeInfoDb_1.28.4
## [23] IRanges_2.26.0 S4Vectors_0.30.2
## [25] BiocGenerics_0.38.0 reshape2_1.4.4
## [27] forcats_0.5.1 stringr_1.4.0
## [29] dplyr_1.0.8 purrr_0.3.4
## [31] readr_2.1.2 tidyr_1.2.0
## [33] tibble_3.1.6 ggplot2_3.3.5
## [35] tidyverse_1.3.1 zoo_1.8-9
##
## loaded via a namespace (and not attached):
## [1] readxl_1.3.1 backports_1.4.1 fastmatch_1.1-3
## [4] systemfonts_1.0.3 plyr_1.8.6 polylabelr_0.2.0
## [7] splines_4.1.3 BiocParallel_1.26.2 digest_0.6.29
## [10] htmltools_0.5.2 fansi_1.0.2 magrittr_2.0.2
## [13] memoise_2.0.1 tzdb_0.2.0 Biostrings_2.60.2
## [16] annotate_1.70.0 modelr_0.1.8 svglite_2.1.0
## [19] prettyunits_1.1.1 colorspace_2.0-2 blob_1.2.2
## [22] rvest_1.0.2 haven_2.4.3 xfun_0.29
## [25] crayon_1.4.2 RCurl_1.98-1.6 jsonlite_1.7.3
## [28] genefilter_1.74.1 survival_3.2-13 glue_1.6.1
## [31] polyclip_1.10-0 gtable_0.3.0 zlibbioc_1.38.0
## [34] XVector_0.32.0 webshot_0.5.2 DelayedArray_0.18.0
## [37] scales_1.1.1 DBI_1.1.2 Rcpp_1.0.8
## [40] progress_1.2.2 viridisLite_0.4.0 xtable_1.8-4
## [43] bit_4.0.4 htmlwidgets_1.5.4 httr_1.4.2
## [46] RColorBrewer_1.1-2 ellipsis_0.3.2 farver_2.1.0
## [49] pkgconfig_2.0.3 reshape_0.8.8 XML_3.99-0.8
## [52] sass_0.4.0 dbplyr_2.1.1 locfit_1.5-9.4
## [55] utf8_1.2.2 labeling_0.4.2 tidyselect_1.1.1
## [58] rlang_1.0.1 later_1.3.0 AnnotationDbi_1.54.1
## [61] munsell_0.5.0 cellranger_1.1.0 tools_4.1.3
## [64] cachem_1.0.6 cli_3.1.1 generics_0.1.2
## [67] RSQLite_2.2.9 broom_0.7.12 evaluate_0.14
## [70] fastmap_1.1.0 yaml_2.2.2 knitr_1.37
## [73] bit64_4.0.5 fs_1.5.2 caTools_1.18.2
## [76] KEGGREST_1.32.0 mime_0.12 xml2_1.3.3
## [79] compiler_4.1.3 rstudioapi_0.13 png_0.1-7
## [82] reprex_2.0.1 geneplotter_1.70.0 bslib_0.3.1
## [85] stringi_1.7.6 highr_0.9 desc_1.4.0
## [88] lattice_0.20-45 Matrix_1.4-0 vctrs_0.3.8
## [91] pillar_1.7.0 lifecycle_1.0.1 jquerylib_0.1.4
## [94] data.table_1.14.2 bitops_1.0-7 httpuv_1.6.5
## [97] R6_2.5.1 promises_1.2.0.1 KernSmooth_2.23-20
## [100] gridExtra_2.3 assertthat_0.2.1 rprojroot_2.0.2
## [103] withr_2.4.3 GenomeInfoDbData_1.2.6 hms_1.1.1
## [106] grid_4.1.3 rmarkdown_2.11 shiny_1.7.1
## [109] lubridate_1.8.0
END of report